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A HISTOMORPHOLOGICAL STUDY OF POLYPS AND POLYPOID LESIONS OF 
GASTROINTESTINAL TRACT WITH SPECIAL REFERENCE TO COLONIC 
NEOPLASTIC POLYPS 
INTRODUCTION: 
A polyp is a tumorous mass that projects above the surrounding mucosa and protrudes 
into the lumen of the gut. Polyps of Gastro-Intestinal tract (GIT) are seen in a wide age range and 
may arise as a result of inflammation, ectopia, hamartomatous or neoplastic proliferation. 
Majority of GIT polyps are sporadic in nature. Familial polyposis syndromes have also been 
described and show a high propensity for malignant transformation. Amongst the colonic polyps, 
adenomatous polyps are the commonest lesions. Various genes have been implicated in the 
progression of adenoma to carcinoma. Study of these genes can help in the development of tools 
for early detection of malignant transformation. 
AIMS AD OBJECTIVES: 
1. To study the incidence and morphology of (a) different types of polyps and polypoid lesions 
of gastrointestinal tract (b) malignancies associated with polyps. 
2. To study nuclear p53 accumulation and bcl-2 gene mutations in colonic neoplastic polyps 
with and without coexisting carcinomas 
MATERIALS AND METHODS: 
The study sample consisted of 452 specimens covering a period of four and a half years. 
The study material included all lesions identified as polyps or polypoid lesions in the gastro-
intestinal tract. The specimens were collected along with relevant clinical details and submitted 
for histopathological examination. Cases with both colorectal adenomas and cancers present in 
the same patient were selected for Immunohistochemical study of p53 and bcl2 expression. The 
control group consisted of patients with isolated colorectal adenomas without any evidence of 
malignancy.  
RESULTS: 
• Polyps and polypoid lesions of GIT constitute  0.745% of all specimens submitted for 
histopathological examination  at a tertiary care centre over four and a half  year period. 
• Majority of cases involved the large intestine (59.53%) followed by stomach 
(26.55%).The age group ranged from 13 yrs to 88 yrs and a male predominance was noted in all 
the sites except for stomach where females outnumbered males. 
• The esophageal lesions were commonest at the lower end of esophagus and were 
predominantly changes of GERD.The stomachlesions were commonly hyperplastic polyps 
seated at the antrum.  
• Duodenum was the predominant site of involvement in the small intestine (85.72%). 
Hyperplastic polyps were the commonest polyps seen. 
• Colonic lesions were predominantly left sided (59.12%) with the rectum being the 
commonest site.Adenomatous polyps constituted the bulk of large bowel polyps (44.61%). 
• 5 cases of adenomatous polyps showed malignant change (4.2%).5 cases showed 
multiple (more than 100) adenomatous polyps involving the large intestine. 16 cases of 
adenomatous polyps (13.33% of adenomatous polyps) were associated with non-contiguous 
colonic cancers which is much higher than other studies worldwide. 
• P53 expression was found to be higher in polyps with contiguous or non-contiguous 
malignancies (61.9%) than in polyps without them (43.75%). They were much higher in the co-
existing cancers (76.2%).Bcl2 expression was found to be variable in the three groups. 
CONCLUSION: 
Polyps and polypoid lesions in the gastrointestinal tract may vary from asymptomatic incidental 
findings and benign harmless lesions to invasive malignancies. A careful study of adenomatous 
polyps is needed in view of potential for malignant transformation. This study finds a high 
incidence of colonic adenomatous polyps with synchronous colonic malignancies which 
indicates the need for cost effective screening guidelines so as to detect the lesions earlier. 
Genetic studies are needed to establish predictive and prognostic markers for malignant 
transformation of adenomatous polyps. 
A polyp is a tumorous mass that projects above the surrounding 
mucosa and protrudes into the lumen of the gut. Polyps of Gastro-
Intestinal tract (GIT) are common in the 6th to 7th decade, though they 
may occur in any age. They may be seen in oesophagus, stomach and 
small intestine but are most commonly seen in the colon. They may arise 
as a result of inflammation, ectopia, hamartomatous or neoplastic 
proliferation.  Polyps have to be differentiated from pseudopolyps, which 
represent areas of inflamed and regenerating mucosa that projects above 
the level of the surrounding frequently ulcerated mucosa. Pseudopolyps 
are commonly seen in localised or generalised inflammatory diseases of 
the GIT such as ulcerative colitis or Crohn’s disease.  
Majority of GIT polyps are sporadic in nature. Familial polyposis 
syndromes are rare autosomal dominant syndromes with a high 
propensity for malignant transformation. They usually present with 
multiple polyps and show early conversion to malignancy. Sporadic 
polyps may be asymptomatic, being discovered only in autopsy studies or 
symptomatic, sometimes with serious complications such as 
intussusception. They may also be manifestations of benign or malignant 
neoplasms, underscoring the significance of the lesion. 
Various endoscopic techniques have helped the identification and 
sampling of polyps and polypoid lesions in various parts of 
gastrointestinal tract. Clinical details and endoscopic findings are 
essential to interpret these biopsies correctly.  
Polyps of gastrointestinal tract may be classified as non-neoplastic 
or neoplastic. The non-neoplastic polyps include inflammatory polyps, 
hyperplastic polyps, hamartomatous polyps and lymphoid polyps. 
Neoplastic polyps are broadly called as Adenomas. Though the non-
neoplastic polyps are grouped so, they may be associated with 
malignancies elsewhere. 
Many other lesions may mimic as polyps endoscopically, including 
Mesenchymal and lymphoid tumours. The commonest type of polyp 
varies in different parts of gastrointestinal tract, such as hyperplastic 
polyps in the stomach and adenomatous polyp in the large intestine. The 
natural course of the polyp has been difficult to study, as they are usually 
completely excised as a part of diagnostic procedure. However, various 
genetic studies and familial syndromes have helped understand the 
pathogenesis of polyps, especially in cases of colonic cancers arising 
from adenomatous polyps.  
The incidence of neoplastic polyps and colorectal cancers is bound 
to increase in low prevalence countries like India due to westernization of 
diet. Genetic studies are yet to provide definitive predictive markers of 
development of colonic cancer. 
CLASSIFICATION OF POLYPS: 
Non neoplastic polyps are classified as  
1. Hyperplastic polyps  
2. Hamartomatous polyps includes juvenile polyps, Peutz-Jeghers 
polyps, Cowden syndrome and Cronkite Canada syndrome 
3. Inflammatory polyps 
4. Lymphoid polyps 
Neoplastic polyps include 
1. Tubular adenomas 
2. Villous adenoma 
3. Tubulovillous adenoma 
Certain diseases may present as polypoidal lesions. They are as follows : 
In the oesophagus  : 
 
 
 
Benign  1. Squamous papilloma 
2. Gastric heterotopia 
3. Glycogenic acanthosis 
 Epithelial lesions 
4. Polypoid dysplasia in 
Barrett’s oesophagus 
Malignant  1. Spindle cell carcinoma 
2. Conventional squamous 
cell carcinoma(rare) 
3. Conventional 
Adenocarcinoma (rare) 
 
 
 
Mesenchymal lesions 
 
 
Benign  
1. Granular cell tumour 
2. Leiomyoma 
3. Fibrovascular polyps 
4. Inflammatory 
myofibroblastic tumour 
 
Malignant  
1. GIST 
2. Leiomyosarcoma (rare) 
 
In the stomach: 
 
Presenting as 
hyperplastic polyps 
1. Polypoid foveolar hyperplasia 
2. Gastritis cystic polyposa / profunda 
3. Menetrier’s disease 
Presenting as Polypoid gastritis 
inflammatory polyps 
 
Presenting as 
heterotopic polyps 
1. Pancreatic heterotopias  
2. Pancreatic acinar metaplasia 
3. Brunner’s gland hyperplasia 
Others 1. Carcinoid tumour 
2. GIST 
3. Inflammatory myofibroblastic tumour 
 
In the small intestine : 
 
Endocrine tumour 
1. Carcinoid tumour 
2. Somatostatinoma 
3. Gastrinoma  
 
Mesenchymal tumours 
1. GIST 
2. Lipoma 
3. Hemangioma 
4. Neurofibroma  
Lymphoid lesions  1. Nodular lymphoid hyperplasia 
2. Diffuse large B cell lymphoma 
3. Mantle cell lymphoma (lymphomatous 
polyp) 
4. Low grade B cell lymphoma 
5. T cell lymphoma 
 
In the large intestine 
1. Ganglioneuroma 
2. Neurofibroma 
3. Granular cell tumour 
4. GIST 
5. Lipoma 
6. Pneumatosis coli 
7. Endometriosis 
8. Mucosal pseudolipomatosis 
9. Malakoplakia  
 
 
 
 
 
 
 1. To study the incidence and morphology of different types of polyps 
of gastrointestinal tract presenting at Madras Medical College. 
2. To analyze the incidence and morphological features of 
malignancies associated with polyps. 
3. To study nuclear p53 accumulation and bcl-2 gene mutations in 
colonic neoplastic polyps with and without coexisting carcinomas 
 
 
 
 
 
 
 
 
 
 
POLYPS AND POLYPOID LESIONS OF ESOPHAGUS 
 Epithelial tumours presenting clinically as polyps include 
adenomas, squamous cell carcinoma, sarcomatoid carcinoma, 
adenocarcinoma and rarely malignant melanoma. Adenomas of 
oesophagus are rare polypoid tumours that represent raised dysplasia in 
Barrett’s oesophagus. They may be multiple and present with 
synchronous adenocarcinoma
1 
. 
 Superficial squamous cell carcinomas may be polypoidal or 
verrucous². Well differentiated verrucous type presents as large warty 
lesion. Microscopically they present as broad papillae of well 
differentiated keratinising squamous epithelium with minimal cytological 
atypia; they invade underlying tissue as bulbous epithelial tongues. 
 Sarcomatoid or spindle cell carcinomas otherwise called polypoid 
carcinomas occur in middle age or elderly men. They present as bulky 
polypoid masses reaching large sizes (upto 15 cm in length) in the mid or 
lower third of oesophagus. 
 Adenocarcinoma of oesophagus show high grade dysplasia in a 
background of Barrett’s type epithelium. Malignant melanoma presents 
as polypoid intraluminal growth; microscopically, they resemble the 
epitheloid and spindle cell types seen in cutaneous melanoma. 
 Smooth muscle tumours most commonly arising in esophagus 
include Leiomyoma and Leiomyosarcoma. Leiomyoma presents as 
polypoidal growth covered by mucosa that may ulcerate. Cut surface 
appears bulging and grey whorled. Microscopically, the tumour cells are 
arranged in interlacing fascicles and have eosinophilic cytoplasm with 
blunt ended cigar shaped nuclei. 
 Fibrovascular polyp presents at upper third of esophagus as solitary 
pedunculated polyps with core of edematous fibrous tissue. Large polyps 
may cause obstruction or asphyxia owing to compression of larynx or 
may regurgitate into posterior pharynx. Rare  case of squamous cell 
carcinoma arising in a giant fibrovascular polyp has been reported by 
Cokelaere K et al.
3
 
 Inflammatory fibroid polyps are rare lesions composed of fibrous 
and granulation tissue with spindle shaped fibroblasts arranged 
concentrically around blood vessels. LiVolsi VA et al
4 
 in his study has 
reported 4 cases of inflammatory fibroid polyp which may be mistaken 
for a leiomyoma both radiographically and on the operating table. 
 Hyperplastic polyps at the gastro-esophageal junction are due to 
chronic mucosal injury such as erosive esophagitis and GERD. In a study 
of 30 hyperplastic polyps of esophagus by Abraham SC et al
5
, 67% of 
them were at the gastro-esophageal junction and were associated with 
ulcers or erosive esophagitis. 
 
POLYPS AND POLYPOID LESIONS OF STOMACH 
 Adenomas of stomach arise in context of atrophic gastritis with 
intestinal metaplasia
6,7
. They are usually solitary, sessile or pedunculated
8
 
and have potential for malignant transformation. In a study of 357 cases 
of gastric polyps by Laxen et al
9
, 8% (27 cases) had gastric adenomas. In 
14 cases carcinoma was found within polyp and in 13 cases carcinoma 
was found outside the polyp. Carcinoma was found in 38% of adenoma 
cases. 
 Gastric adenomas may co-exist with carcinoma elsewhere in 
stomach especially in males
10
. Nakamura and Nakano
11
 have studied 611 
gastric polyps from 275 cases and classified them into 4 subtypes. In type 
1, which comprise 60 to 80%, polyps were solitary, pedunculated and 
situated at the pyloric antrum. They are composed of irregularly 
proliferating non dysplastic glands and cysts. The glands are lined by 
high columnar epithelial cells without dysplasia. Type 2 polyps are 
multiple and located in the distal fundic mucosa of stomach. They have 
pink dimples which microscopically correspond to superficial erosion. 
The polyp is lined by hyperplastic regenerative epithelium at the center 
and hyperplastic foveolae, fundic glands and cysts at the periphery. Type 
3 polyps are sessile and located at the pyloric antrum. Histologically, they 
have a characteristic two layered structure-upper layer of densely 
arranged vertical glands lined by darkly staining columnar cells with 
hyperchromatic nuclei and stratification and lower layer is composed of 
hyperplastic pyloric glands, ducts and multiple cysts. Type 3 polyps are 
further subdivided into 3 groups based on the degree of proliferation of 
non-dysplastic glands in lower layer. Type 4 polyps resemble colonic 
polyps grossly. They are sessile or pedunculated, surface showing fine 
lobulations, with inter communicating clefts. Mild/moderate/severe 
dysplasia was noted. The lining epithelium is columnar which appears 
hyperchromatic with elongated oval or round nuclei. The polyps may 
show tubular/villous/tubulovillous architecture. Malignant change was 
absent in types 1 & 2, focal in type 3 and maximum in type 4. 
 Hyperplastic polyps are the most common type of gastric polyps. 
They arise in association with H.pylori associated gastritis, pernicious 
anemia or ulcers/erosions in a background of atrophic gastritis with 
intestinal metaplasia. They may increase or regress with time. 2 to 3% of 
hyperplastic polyps of size more than 2 cm show dysplasia or 
intramucosal carcinoma and may be associated with synchronous 
adenocarcinoma of stomach. T Hattori
12
 has studied the morphology of 
67 hyperplastic polyps of which 18 showed intestinal metaplasia. 3 
polyps showed intestinal type adenocarcinoma and 2 showed gastric type 
adenocarcinoma. 
 Inflammatory fibroid polyps are seen in association with 
hypochlorhydria or achlorhydria and are seen at the antrum. 
Histologically they are similar to their esophageal counterparts. 
 Gastritis cystica polyposa/profunda by definition is a hyperplastic 
polyp showing misplaced foveolar or glandular epithelium in the 
muscularis mucosae or submucosa or muscularis propria. When the gross 
appearance is that of an intraluminal polyp, the lesion is called polyposa, 
whereas profunda refers to the bulk of the lesion located in the wall of the 
stomach. These lesions are seen in patients with chronic bile reflux, 
usually in post-gastrectomy status. The pathogenesis is unclear; the lesion 
may be induced by the entrapped epithelium causing excess reactive 
tissue formation. These lesions are usually seen on the gastric side of 
gastro-enteric anastomoses. Histologically the entrapped epithelium may 
be mucinous or glandular and cystic, surrounded by lamina propria like 
stroma with inflammatory infiltrate. Dense collections of smooth muscle 
surround the cysts, the lining of which may show hyperplasia or 
metaplasia. 
 Fundic gland polyps occur sporadically or as component of 
Familial Adenomatous Polyposis. They are usually multiple, glassy, 
transparent and sessile. Microscopically, the polyp shows cystically 
dilated glands lined by fundic epithelium admixed with normal glands. 
 Peutz-Jeghers polyps are hamartomatous polyps which may show 
dysplasia or even frank carcinoma. Cochet
13
 et al have described two 
cases of metastasizing gastrointestinal carcinomas arising from 
hamartomatous polyps and showed extensive metastasis. Both cases 
showed dysplastic areas within hamartomatous polyps. 
 Juvenile polyps are rare in stomach. They may occur at any age 
and produce anemia and hypoproteinemia. Multiple juvenile polyps are 
seen in Juvenile Polyposis syndrome which is associated with an 
increased risk of carcinoma of colorectum and also the stomach. In a 
study by Hizawa
14
 et al, 12 cases of juvenile polyposis involving stomach 
at initial presentation were compared with 29 cases of generalised 
juvenile gastrointestinal polyposis. They concluded that juvenile 
polyposis of stomach has malignant potential and is a separate entity from 
generalised gastrointestinal polyposis. 
 Of the heterotopias, pancreatic heterotopias are the most common 
in the stomach; it occurs in the pylorus or antrum as conical or short 
cylindrical mass. 
 Menetrier’s disease presents grossly as hypertrophic rugae of 1 to 3 
cm height or may resemble polyposis of body and fundus when uneven 
and nodular. It is said to be associated with an increased risk of gastric 
cancer and requires life-long surveillance due to its chronic nature
15
. 
 Gastric adenocarcinomas present as polypoid, fungating, ulcerating 
or diffusely infiltrating growth. Polypoid growths are more common in 
the corpus and greater curvature. M S Wu
16
 has studied the expression of 
p53 in different subtypes of intestinal metaplasia and gastric cancer. 135 
gastric cancer specimens were evaluated for p53 expression in cancerous 
epithelium and adjacent intestinal metaplastic epithelium. The study 
concluded that type 3 intestinal metaplasia is the most common lesion in 
dysplasia-carcinoma transition especially in intestinal type gastric cancer. 
 Primary gastric B cell lymphomas occur in middle aged or elderly 
in a background of H.Pylori induced gastritis. They present as polypoid, 
fungating or ulcerating tumours at the antrum. 9 cases of synchronous 
adenocarcinoma and low grade B cell lymphoma of MALT type have 
been described by Wotherspoon et al
17
. 
 Malignant lymphomatous polyposis characterised by multiple 
gastric polyps or as a generalised thickening of rugal folds giving a 
cerebriform appearance. They are mostly Mantle cell lymphomas. 
Microscopically, they show small lymphoid cells with folded nuclei 
forming monotonous infiltrates. Lymphoepithelial lesions are rare. 
 Up to 30% of GI carcinoid tumors occur in the stomach.  They 
occur most commonly in the body and fundus in middle aged individuals. 
They are usually asymptomatic and are associated with endocrine cell 
hyperplasia. WHO classifies gastric carcinoids into 4 types: Types 1, 2 
and 4 are associated with hypergastrinemia whereas type 3 is sporadic. 
Microscopically gastric carcinoids are composed of small uniform 
polygonal or cuboidal cells with finely granular cytoplasm, regular round 
nuclei, stippled chromatin and scant mitosis. They are argyrophilic and 
show expression of chromogranin A, synaptophysin, PGP 9.5 and leu-7. 
 The stomach is the commonest site for GISTs, constituting 
approximately 60% of all cases. Gastric GISTS predominantly show 
epithelioid features. The median age of occurrence is 60 yrs with fundus 
being the commonest site. Grossly, GISTs are solitary intramural 
tumours. However, predominantly extramural and dumbbell forms are 
also encountered. Malignant GISTs are predominantly expansile and 
rarely infiltrate adjacent tissues. External surface is granular and rubbery. 
On cut section, they are characteristically grey and lacking trabeculations 
or whorling pattern. The tumour cells of gastric GISTs are predominantly 
uniform spindle cells arranged in fascicles and showing oval blunt-ended 
nuclei and abundant eosinophilic cytoplasm. Epithelioid GISTs are rare 
and show sheets of round cells with clear cytoplasm, cellular 
pleomorphism and bizarre nuclei. Both subtypes show hyalinization and 
myxoid degeneration. CD117(c-kit) and CD34 are the important markers 
for diagnosis.  
POLYPS AND POLYPOID LESIONS OF SMALL INTESTINE 
 Adenomas of small intestine are rare and are commonly seen in 
peri-ampullary region; they are usually multiple, sessile and villous. 
Perzin K H and Bridge M F
18
 have studied 51 patients with small bowel 
adenomas. Of them, 18 had adenomas and 33 had tumours containing 
both adenomas and adenocarcinomas in the same lesion. Of the 33 cases, 
5 were intramucosal carcinoma and 28 were invasive carcinomas. Their 
study concluded that adenomas of small intestine were probably pre-
malignant lesions and many primary adenocarcinomas arise from these 
adenomas. According to their study, carcinomas tend to occur more 
frequently in villous adenomas, larger lesions and at the ampullary 
region. 
 Adenocarcinomas are polypoid or ulcerating tumours most 
common at peri-ampullary region. Talbot I C
19
 et al have studied 26 
ampullary carcinoma resection specimens of which 25 were intestinal 
type adenocarcinomas and 1 case was papillary adenocarcinoma. Co-
existing adenomas were seen in 11 cases, over half of which were low 
grade carcinomas. 
 Lymphoid polyps tend to occur in children and present with right 
iliac fossa pain, obstruction or intussusception. 
 Other polyps and polypoidal lesions include Brunner gland 
hamartoma, Peutz-Jeghers polyp, juvenile polyps, pancreatic heterotopia 
and Inflammatory fibroid polyp. 
 Peutz-Jeghers polyps arise most commonly in small intestine. They 
may be sporadic or a part of Peutz-Jeghers syndrome which included GI 
polyposis, oral pigmentation and an increased risk of cancer of GIT, 
pancreas, breast, ovary, uterus and lung. An autosomal dominant disease, 
Peutz-Jeghers syndrome is due to mutations in LKB1 gene on 
chromosome 19p. Grossly, PJ polyps may be sessile or pedunculated with 
a short broad stalk. Histologically, the polyps show branching core of 
smooth muscle arising from muscularis mucosa and covered by normal 
appearing epithelium and lamina propria. Dysplasia and malignancy are 
rarely seen. 
 The small bowel GISTs constitute 25–30% of all GISTs. Though 
ileum is the commonest site, a substantial number of cases occur in 
duodenum also. The histological types seen are similar to those in 
stomach, but the epithelioid GISTs are uncommon in the small intestine. 
Low grade small bowel GISTs are paucicellular spindle cell stromal 
tumours arranged in organoid pattern with extracellular skenoid fibres 
and show mitotic rate of <2/50 hpf. Whereas, aggressive tumours are 
characterized by high cellularity, less organoid morphology, necrosis and 
high mitotic rates. Size, cellularity and mitotic index are the most 
important prognostic factors in jejunal and ileal GISTs. The 
immunohistochemical markers are similar to those of GISTs elsewhere. 
 Endocrine tumors of small bowel are commonest in the ileum and 
rare in the duodenum. Grossly, they present as smooth, tan-yellow, 
submucosal polypoid masses. Most serotonin-producing endocrine 
tumors are seen in the distal small intestine and are extremely rare in the 
duodenum. The serotonin produced by these tumours elicits peritumoral 
or mesenteric fibrosis resulting in symptoms of recurrent small bowel 
obstruction, vascular compression (mesenteric angiopathy), and 
protracted abdominal pain. Synchronous or metachronous malignancies 
have been reported including carcinomas of the GI, genitourinary, and 
gynecologic tracts. The tumor cells have abundant amphophilic or faintly 
eosinophilic cytoplasm, round nuclei, stippled chromatin, and 
inconspicuous nucleoli. Necrosis and atypia are absent, though perineural 
and lymphovascular invasion may be present. 
 
POLYPS AND POLYPOID LESIONS OF LARGE INTESTINE 
 These include : 
1. Adenomatous polyps : Tubular, Villous, Tubulovillous 
2. Hyperplastic polyps 
3. Inflammatory polyps 
4. Hamartomatous polyps : juvenile polyps 
 Peutz-Jeghers polyps 
 Polyps in Cronkite-Canada syndrome 
 Polyps in Cowden syndrome 
5. Lymphoid polyps and malignant lymphomatous polyposis 
6. Colorectal carcinomas 
7. Mesenchymal polyps 
 
 ADENOMA : 
 Adenoma is a circumscribed benign epithelial neoplasm with a 
potential for malignant change. 
 Adenomas of large intestine are more commonly seen in 
populations at risk for colorectal carcinomas
20, 21
 as demonstrated by 2 
autopsy studies. 
 They are more common in males in all regions of colon; but the 
risk of carcinoma in females is more at the rectum. This is because 
adenomas in females tend to be larger and more dysplastic
22, 23, 25
 with a 
higher conversion rate to carcinoma. Hoff G et al
22
 examined 50 polyps 
obtained by endoscopic screening of rectosigmoid polyps. Of these 41 
were adenomas. Adenomatous polyps were found in both proximal and 
distal colon in males, but greater extent of dysplasia was found in 
rectosigmoid adenomas in women. 
 Adenomas are generally evenly distributed along the length of 
large intestine. However, carcinomas differ in site distribution as they are 
more common in rectum and distal colon. This is due to higher 
conversion rate of adenoma to carcinoma in the rectum
21, 24
. 
 Usually asymptomatic, adenomas may present with occult rectal 
bleeding, or water and electrolyte depletion. 
 Adenomas may be inherited in an Autosomal Dominant mode as 
shown by Burt RW et al
26
 and Aitken et al
27
. 
 The significance of adenomas lies in the fact that they serve as 
precursor lesions for colorectal carcinoma. However as the prevalence of 
adenomas is 30 times more than that of carcinoma, it is probable that only 
a small proportion of adenomas will turn malignant
28
. 
 Adenomas may be sessile or pedunculated; sessile ones resemble 
hyperplastic polyps and pedunculated polyps are cauliflower-like. 
 Flat adenomas refer to adenomas without a polypoid component. 
As the name suggests, they are flat lesions with elevated edges. Cases of 
multiple hereditary flat adenomas reported in the past represent 
Attenuated FAP. The behaviour and prognosis of solitary flat adenomas 
are found to be similar to pedunculated adenomas. 
 Histologically, adenomas are divided into tubular, villous and 
tubulovillous adenomas. By definition, all are lined by dysplastic 
epithelium which are immature cells with enlarged, hyperchromatic and 
stratified nuclei. Increased mitotic activity is seen in surface epithelium 
and upper crypts. Architectural abnormalities are noted. 
 Tubular adenomas show branching tubules constituting atleast 80% 
of the neoplasm. They are usually pedunculated. Villous adenomas show 
atleast 80% of the tumour constituted by leaf-like or finger-like processes 
of lamina propria covered by dysplastic epithelium. They are usually 
sessile and large. Tubule-villous adenomas show both components 
neither more than 80%. 
 Adenomas are classified based on degree of dysplasia into mild, 
moderate and severe dysplasia. Mild dysplasia is characterised by low 
nuclear cytoplasmic ratio with elongated, crowded and stratified nuclei 
and with preserved mucin secretion. Moderate dysplasia is characterised 
enlarged, hyperchromatic and pseudostratified nuclei with very few 
goblet cells. Severe dysplasia is characterised by enlarged and 
hyperchromatic nuclei with prominent nucleoli and architectural 
abnormalities like crowded and back to back glands. 
 The term carcinoma in situ is used when architecture is that of 
malignancy but the line of invasion has not crossed muscularis mucosa. 
 Mixed polyp shows features of hyperplastic polyp and adenoma. 
 Serrated adenomas show the features of adenomatous dysplasia 
and epithelial serration. They are related to hyperplastic polyps 
histogenetically. Both share certain phenotypic and genotypic alterations. 
Torlakovic E et al
29
, in a study on morphological reappraisal of serrated 
colorectal polyps, identified a distinct group of serrated polyps with 
abnormal proliferation. These polyps show decreased expression of 
hMHL1 and hMSH2 compared to polyps with normal proliferation. They 
recommend evaluation of site, size and morphological features when 
serrated polyps are included in colorectal carcinogenesis research. 
 Sessile serrated adenomas are more commonly located in proximal 
colon and relatively large. They show dilated crypts, exaggerated 
serrations but lack overt dysplasia. These hyperplastic like polyps are 
linked to subsets of colonic cancer via DNA methylation, BRAF mutation 
and DNA MSI pathway
30
.  
 Familial Adenomatous Polyposis (FAP) is an autosomal dominant 
disorder characterised by hundreds of adenomas throughout colon. The 
genetic mutation involves APC gene on chromosome 5q, a rare 
autosomal recessive type with mutation in gene MYH has been 
recognised
31
. Mutations in exon 3 and 4 of APC gene causes attenuated 
FAP with fewer numbers of adenomas that are right sided and flat. In 
FAP, adenomas are usually tubular and are also found at other sites 
namely duodenum, ileum and antrum of stomach. Non GI lesions have 
also been described. 
 Gardner’s syndrome in which APC gene mutation is at 3’ end is 
characterised by multiple osteomas of skull and mandible and multiple 
epidermal cysts of skin
32
. Also seen are mesenteric and abdominal wall 
fibromatosis, soft tissue fibroids, dental cysts, retinal pigmentation, 
thyroid cancers and medulloblastoma. 
 Turcot’s syndrome is characterised by FAP and CNS tumours- 
glioblastoma and medulloblastoma. They are now considered as cases of 
either FAP or HNPCC
33
.  
 
 COLORECTAL CARCINOMA 
 EPIDEMIOLOGY : Colorectal carcinoma is one of the commonest 
carcinoma in the west but of low incidence in India. In a study by Sinha
34
 
et al, incidence in the United states was found to be 40.6(men) and 
30.7(women) per lakh population whereas the incidence rate in India is 
4.7(men) and 3.2(women) per lakh population. In another study by 
Mohandas K M and Desai D C
35
, the incidence of colonic cancer in 8 
population registries vary from0.7 to 3.7 (men) and 0.4 to 3(women) per 
lakh population. For rectal cancer, incidence rates range from 1.6 to 
5.5(men) and 0 to 2.8(women) per lakh population. He also found that 
incidence rates for large bowel cancer in rural India is approximately half 
of that in urban India. Rectal cancer was also found to occur more 
commonly in young Indians. 
 ETIOLOGY: This consists of both environmental and genetic 
factors, the latter being important. Environmental factors include diet 
especially increased meat consumption and alcohol. Vegetable fibre plays 
an important protective factor. Genetic factor plays an important role in 
adenoma formation. 
 Carcinoma right colon is more common in females at all ages36. 
Carcinoma of left colon is more frequent in females under 50 yrs and in 
males over 70 yrs. The excess of carcinoma of right colon in individuals 
under 50 yrs is explained by the fact that HNPCC occurring in younger 
individuals involve the right colon. Isbister WH and Fraser J
37
 studied the 
survival rate of young patients with CRC and concluded there was no 
evidence to suggest that younger patients ( younger than 40 yrs) with 
CRC had worse prognosis and did not survive as long as older 
patients(more than 40 yrs). 
 The subset of CRCs associated with MSI and DNA methylation is 
associated with female gender, proximal location and age
38
. 
 Studies have shown that a large number of CRCs arise from pre-
existing adenomas
39
 and de novo carcinomas may arise from flat 
adenomas. 
 HNPCC constitutes 1 to 5% of CRCs; it is due to defect in DNA 
mismatch repair gene MSH2, MSH6, MLH1 and PMS2
40
. In HNPCC, 
cancer tends to occur in right colon. Jass JR and Stewart SM
41
 studied the 
prevalence of colorectal adenomas in 23 patients of HNPCC and 
compared it with age matched controls. Of the adenomas found in these 
patients, 9 were >1 cm and 6 of them were of the villous type. 
Contiguous adenocarcinomas were found in 6 adenomas. They concluded 
that adenomas in HNPCC were found in small numbers at a younger age 
and were of large size and villous type. Their conversion rate to 
malignancy was higher than that of sporadic cancer.  
 Grossly, CRC may be ulcerating (most common), annular or 
protruberant types. Microscopically, 90% of CRCs are adenocarcinomas 
with tubular differentiation. Loy TS and Kaplan PA
42
 reviewed 420 cases 
of CRCs of which 95 tumours showed villous architecture. Those 
showing more than 50% villous architecture were designated as villous 
adenocarcinomas and were diagnosed by identifying epithelial islands in 
desmoplastic stroma. They found that villous adenocarcinoma carried a 
good prognosis 
 Mucinous adenocarcinomas are diagnosed when more than 50% of 
tumour consists of mucus. Signet ring cell carcinoma in large bowel is 
rare (1% of large bowel carcinoma). More than 50% of tumour is 
constituted by cells containing intracytoplasmic mucin. Other types 
include squamous cell carcinoma, adenocarcinoma, small cell carcinoma 
and undifferentiated carcinoma. 
 
 GENETICS OF COLORECTAL CARCINOMA : 
The syndromes of FAP and HNPCC are characterised by mutations 
in APC and DNA mismatch repair genes respectively. The evolution of 
adenoma to carcinoma and the genetic alterations in the evolution of CRC 
has been studied by Vogelstein et al
43
. 4 genetic alterations (K-ras, APC, 
Tp53 and del 18) were studied. Their study showed that alterations in  
APC, Kras and p53 were the principle events in the initiation, 
transformation and progression to adenocarcinoma. However this 
transformation does not involve a single linear pathway. In a study by 
Gillian Smith et al
44
 38.7% of tumours had mutations in one of the 3 
genes. The most common combination was APC and p53. 
Various genes have been implicated at several stages in the 
progression of adenoma to carcinoma. The important initial event in this 
neoplastic process is the loss of both copies of APC gene at chromosome 
5q21. This causes normal epithelium to transform into adenomatous 
epithelium. Homozygous loss of p53 is one of the events in the 
transformation of adenoma to carcinoma, others including LOH of 
SMAD 2 and 4 genes. This is followed by further additional mutations 
and chromosomal alterations. This classic model was proposed by 
Vogelstein and has been propagated for carcinogenesis at other sites also. 
However, these genetic changes are not always detectable in all the 
polyps and may not strictly follow the same sequence. 
ADENOMA – CARCINOMA  SEQUENCE : 
 
Normal 
mucosa  
First hit - 
APC(5q21) 
Mucosa at 
risk   
 Second hit -
APC, Beta 
catenin 
Adenoma  
KRas, p53, 
SMAD2 & 4 
Carcinoma 
Additional 
mutations : 
telomerase 
 ROLE OF P53 AND BCL2 IN NEOPLASIA : 
P53 is a tumour suppressor gene located at chromosome 17p13.1 . 
It acts as the molecular policeman by preventing propagation of 
genetically damaged cells
45
. P53 gene is the most common gene to be 
altered in human tumours. Mutations in both alleles of p53 lead to cancer. 
TP53 acts by causing cells with irreversible DNA damage to progress to 
apoptosis or senescence. The functions of p53 have been recently found 
to be regulated by a microRNA called mir34 which also acts on other 
genes such as cyclins and bcl2. 
bcl2 was the first anti-apoptotic gene to be identified and is located 
at chr18q21. It is located on the outer leaflet of mitochondrial membrane, 
endoplasmic reticulum and nuclear membrane. Bcl2 family of proteins 
regulate apoptosis by activating the proteolytic enzymes (caspases). 
When factors favouring apoptosis act on the cell, bax gene (a member of 
bcl2 family) causes the exit of cytochrome C from the mitochondria into 
the cytoplasm. Bcl2 exerts its anti-apoptotic effect by blocking this action 
of bax. The released cytochrome C activates the caspases. 
bcl2 expression in the colonic epithelium is normally restricted to 
the crypt base where stem cell proliferation takes place. Bcl2 expression 
is absent in the mature epithelial cells; hence persistent bcl2 expression 
prolongs life span of cells paving the way for tumorigenesis 
INTERACTION BETWEEN P53 AND BCL2: 
Wild type p53 causes its pro-apoptotic action by upregulating the 
transcription of bax gene which counteract the anti-apoptotic action of 
bcl2.  
P53 AND BCL2 IN COLORECTAL NEOPLASMS : 
Various studies have been done on the roles of p53 and bcl2, both 
individual and combined, in colorectal neoplasms. 
1.    In a study by Bosari et al46, bcl2 expression was evaluated 
immunohistochemically in normal colonic mucosa, 24 hyperplastic 
polyps, 49 adenomas and 205 colorectal carcinomas. In normal 
colonic mucosa and hyperplastic polyps, bcl2 was positive in 
proliferating cells of colonic crypts only. Bcl2 positivity was noted in 
all adenomas irrespective of dysplasia. In CRC, bcl2 was not detected 
in 50% cases and focal in 38%. Remaining 12% showed diffuse bcl2 
reactivity. Bcl2 did not have correlation with both clinic-pathologic 
parameters of CRC and p53 accumulation and had no prognostic 
significance. They concluded that bcl2 oncoprotein may play an early 
role in adenoma-carcinoma sequalae and in established tumors has no 
prognostic significance. 
2.    In a similar study by Flohil CC47 et al of bcl2 expression in 
hyperplastic polyp, colonic adenomas and CRC, increased bcl2 
expression was found in most adenomas (31/35) but not in most 
carcinomas (7/10), suggesting that the regulation of apoptosis in 
colorectal epithelia involves additional regulatory factors. 
3.    Diez et al48 studied the influence of tumor localization on the 
prognostic value of p53 protein in colorectal adenocarcinomas and 
found that p53 overexpression was more frequent in distal than in 
proximal tumors. Their study showed that p53 positivity and distal 
tumour location were associated with a higher risk of recurrence. 
4.    Manne U et al49 studied the significance of bcl-2 expression and 
p53 nuclear accumulation in 134 colorectal adenocarcinoma. Nuclear 
accumulation of p53 was detected in 44% of colorectal 
adenocarcinomas and was associated with decreased patient survival. . 
Tumors that did not express detectable levels of bcl-2 but exhibited 
nuclear accumulation of p53 were associated with the shortest patient 
survival. . Although a trend toward an inverse correlation between bcl-
2 and p53 expression was observed, the prognostic value of bcl-2 
expression was independent of p53 status. Thus, assessment of both 
Bcl-2 and p53 status may be valuable in predicting the prognosis of 
patients with colorectal adenocarcinomas. 
5.    Mosnier JF et al50 studied of expression of bcl-2 and p53 
oncogenes in 6 colorectal hyperplastic polyps, 33 adenomas, and 61 
carcinomas. bcl-2 was expressed in 28 (85%) of the 33 adenomas, 
whereas p53 was expressed in only one adenoma, which had areas of 
in situ carcinoma. bcl-2 and p53 were each expressed in 43 (70.4%) of 
the 61 carcinomas. Thirty-one (50%) of the colorectal carcinomas 
coexpressed the two oncoproteins. There was no correlation between 
the number of cells expressing bcl-2 and the number expressing p53 in 
a given carcinoma. No correlation was observed between the 
expression of bcl-2 or p53 and the established prognostic factor. 
Abnormal bcl-2 oncoprotein expression appears earlier than p53 
accumulation in colorectal carcinogenesis. This study suggests that 
there is more than one sequence and mechanism of bcl-2 and p53 gene 
deregulation in colorectal carcinomas. 
6.    Yao et al51 studied the clinicopathological features and the 
expression of p53 and bcl-2 proteins in 50 villous tumors in the age 
group of 32 to 84 years. Their findings were : villous tumours of colon 
and rectum are more common in females and were common in 
sigmoid colon and rectum. 74% of villous adenoma showed high 
grade dysplasia and 34% showed adenocarcinoma with focal or 
diffuse mucin pools. p53 overexpression was seen in 12% of villous 
adenomas and in 18% of invasive component of carcinoma in villous 
adenoma. bcl2 overexpression was seen in 57% of villous adenomas 
and 7% of invasive component of villous adenoma. Several 
characteristic features were recognized in villous tumors, which 
comprised: (i) a high frequency of coexistence of carcinoma; (ii) 
multiple foci of carcinomas arising in adenomatous tumors; (iii) a 
lower histological grade of carcinomas, often with mucin pools; (iv) 
the existence of extremely well-differentiated adenocarcinomas; and 
(v) less frequent expression of p53 protein in the carcinomatous 
components. According to these findings, the pathway of tumor 
progression in the villous tumors is possibly different from that of 
sporadic colorectal carcinomas. Because of the peculiarity of villous 
tumors, careful clinical management is required. 
 
 OTHER POLYPS : 
 HYPERPLASTIC POLYPS : usually asymptomatic, hyperplastic 
polyps are common in rectum and distal sigmoid colon. Hyperplastic 
polyps tend to show spatial clustering as was shown by Cappell MS and 
Forde KA
52
. In their study on relative polyp location in 426 patients with 
multiple colonic polyps, they found that hyperplastic polyps were 
spatially clustered among themselves and with neoplastic polyps 
(adenomas). In a case report by Jeevarathnam et al
53
, the subject had 
multiple large hyperplastic polyps and colorectal carcinoma with DNA 
replication errors. They concluded that giant hyperplastic polyposis is a 
new familial syndrome pre-disposing to CRC. Histologically, 
hyperplastic polyps show elongated crypts with serrated pattern. The cells 
are eosinophilic, columnar with apical mucin, round vesicular nuclei and 
prominent nucleoli. Lamina propria has increased number of smooth 
muscles and decreased number of lymphocytes and plasma cells. Multiple 
hyperplastic polyps have been described in young individuals in whom 
they are larger and occur throughout the large bowel
54
. Though 
hyperplastic polyps are generally considered benign, cases have been 
reported in the past where adenocarcinoma had developed from 
hyperplastic polyps with adenomatous changes
55
. 
 INFLAMMATORY POLYPS: These are seen as a complication of 
inflammatory bowel disease, uretero-sigmoidostomy or mucosal prolapse. 
The polyp is composed of branching dilated crypts with an oedematous 
stroma containing inflammatory cell infiltrate. 
 JUVENILE POLYPS: Juvenile polyps are common in children and 
present with rectal bleeding. They are usually solitary but cases with 
multiple polyps have also been recorded. Juvenile polyps are 
pedunculated with a spherical head. Histologically, the characteristic 
feature is presence of excess edematous lamina propria in the head of the 
polyp with cystically dilated glands lined by normal epithelium. Juvenile 
polyp is a pre-malignant condition, cancer risk being 20%. 
 Lymphoid polyps are benign lesions occurring most common in 
rectum. They occur due to local inflammation and are seen in children 
subsequent to viral infection or due to immune deficiency in familial 
cases. 
 MALIGNANT LYMPHOMATOUS POLYPOSIS/LYMPHOMA :  
High grade B cell lymphomas are rare in large bowel, most common site 
being caecum and rectum. Lymphomas of colon and rectum present as 
multiple polyps which histologically show nodular lymphoid infiltrate of 
mucosa and superficial submucosa. More than 90% cases show Cyclin 
D1 (bcl1) positivity. 
 PJ polyps, hamartomatous polyps of Cowden’s disease, Gastric 
heterotopias and Malakoplakia are the other polypoid lesions. Cowden 
syndrome presents with hamartomatous polyps of GIT, tumours of skin, 
oral mucosa, thyroid and breast. It is an autosomal dominant disease due 
to mutation of PTEN gene on chromosome 10q. 
 MALAKOPLAKIA usually involves sigmoid colon and rectum. 
GIT is the second most common site for malakoplakia after urinary tract. 
It presents as polypoid or plaque like lesion showing large eosinophilic 
histiocytes containing calcified Michaelis Guttmann bodies. It may be 
complicating suppurative carcinoma of large bowel. 
 
Since polyps and polypoid lesions are of common occurrence at various 
sites in the gastrointestinal tract, this study aims at a comprehensive 
analysis of their features and their association with cancers particularly in 
the colon. 
 
 
 
 
 
 
 
 
 
 
 
A total of 60,671 specimens were submitted to the study centre 
from January 2008 to July 2012. Of these, the study sample consisted of 
452 specimens. 
 The study material included all lesions identified as polyps or 
polypoid lesions in the gastro-intestinal tract. The specimens included 
both endoscopic biopsies (polypectomies) and intestinal resection 
specimens showing such lesions. 
 Lesions described as nodules or ulcerated proliferating masses 
were excluded to avoid confusion with other lesions.  
The specimens were collected along with relevant clinical details 
including age, sex, clinical presentation and family history of polyposis or 
GI cancers. The specimens were fixed using 10% Neutral Buffered 
Formalin and processed as for routine histopathological studies using H 
& E stain. Cases with both colorectal adenomas and cancers were present 
in the same patient were selected for Immunohistochemistry. A control 
group was selected by taking patients with isolated colorectal adenomas 
without any evidence of malignancy. The control population was matched 
with the case group for age, sex, site and type of adenomatous polyp. 21 
cases and 16 matched controls were selected and Immunohistochemical 
studies were done on 5 micron sections of paraffin blocks in which 
antigen retrieval was done using Microwave. p53 and bcl2 (Biogenex) 
antibodies were used and their expression identified using DAB 
chromogen. 
Antigen Vendor Species(clone) Dilution 
P53 BIOGENEX Mouse 
Ready to 
use 
Bcl2 BIOGENEX Rabbit  
Ready to 
use 
 
 p53 and bcl2 were considered positive if more than 10% of 
representative epithelium (adenomatous epithelium) showed positivity
56, 
57
. The lymphocytes in lamina propria served as internal control for bcl2.  
Statistical correlation was done using Epi info 7 software. 
 
 
 
 
 
 Total number of polyps and polypoid lesions of Gastro-intestinal 
tract – 452 
 Incidence – 0.745% of biopsies received in the same 4½ years 
period 
TABLE 1 DISTRIBUTION OF POLYPS AND POLYPOID 
LESIONS IN THE GASTRO-INTESTINAL TRACT 
 ESOPHAGU
S 
STOMACH SMALL 
INTESTIN
E 
LARGE 
INTESTIN
E 
No. of 
cases (%) 
7(1.55%) 120(26.55%) 56(12.17%) 269(59.53%
) 
Age range 28 to 65 yrs 16 to 80 yrs 14 to 88 yrs 13 to 85 yrs 
Mean age 47.6 yrs 51 yrs 47 yrs 47 yrs 
No.of male 
patients 
5 54 45 191 
No.of 
female 
patients 
2 66 11 78 
Male:Fema
le  ratio 
2.5:1 1:1.2 4.1:1 2.5:1 
Commones
t site 
And type 
Lower end ; 
Hyperplastic 
squamous 
epithelium 
Antrum ; 
Hyperplastic 
polyp 
Duodenum ; 
Hyperplasti
c polyp 
Left colon ; 
Adenomato
us polyp 
with 
papillomatos
is 
 
ESOPHAGUS: 
TABLE 2 HISTOLOGICAL TYPES OF LESIONS OF 
ESOPHAGUS 
TYPE FREQUENCY(NUMBER OF 
CASES) 
Hyperplastic squamous 
epithelium with papillomatosis 
3 
Barrett’s esophagus 2 
Fibroepithelial polyp 1 
Non-specific inflammation 1 
TOTAL 7 
 
 
 
 
 
 
STOMACH:  
TABLE 3 DISTRIBUTION OF POLYPS AND POLYPOID 
LESIONS IN THE STOMACH BASED ON SITE 
SITE NUMBER OF CASES 
OGJ & CARDIA 5 
FUNDUS 17 
BODY 40 
ANTRUM 43 
PYLORUS 15 
TOTAL 120 
 
TABLE 4 DISTRIBUTION OF POLYPS IN STOMACH BASED 
ON HISTOLOGICAL TYPE 
POLYPS  NUMBER OF CASES 
Hyperplastic polyps 46 
Fundic polyps 2 
Inflammatory polyps 7 
Inflammatory fibroid polyp 1 
Hamartomatous polyp 1 
Adenomatous polyp 9 
          Tubular adenoma 
          Tubulovillous adenoma 
          Villous adenoma 
4 
4 
1 
TOTAL 66 
 
TABLE 5 DISTRIBUTION OF POLYPOID LESIONS IN 
STOMACH BASED ON HISTOLOGICAL TYPE 
POLYPOID LESION NUMBER OF CASES 
ADENOCARCINOMA 16 
NON-SPECIFIC INFLAMMATION 16 
CHRONIC LYMPHOCYTIC GASTRITIS 15 
GIST 1 
MULTIPLE LESIONS 6 
TOTAL 54 
 
 
 
 
TABLE 6 DISTRIBUTION OF HYPERPLASTIC POLYPS IN 
STOMACH BASED ON SITE 
 Hyperplastic polyps Stomach 
Antrum 21 
Body including lesser curvature 16 
Fundus 5 
OG junction 1 
Pylorus 3 
TOTAL 46 
 
 Hyperplastic polyps of stomach were totally 46 cases 
 Age group ranged from 35 yrs to 80 yrs with mean age of 47 yrs 
 More common in females (26 cases vs. 20 cases in males) 
 Most common site – antrum 
 3 cases were pedunculated (6.5%); rest were sessile (93.5%). 
 Two cases showed multiple polyps (4.3%); rest were single 
(95.7%). 
 One male patient aged 50 yrs presented with clinical features of 
peptic ulcer disease and gastric outlet obstruction and was found to 
have a hyperplastic polyp measuring 1.5 cm diameter situated at 
the pylorus; another patient, a 70 yr female patient who had 
cirrhosis with portal hypertension had a hyperplastic polyp at the 
fundus; rest of the patients had symptoms suggestive of peptic 
ulcer disease (epigastric pain, nausea, dyspepsia). 
RARE LESIONS IN STOMACH: 
1. GIST :  
59 yr/male, HIV positive, polypoidal growth in fundus of 
stomach with ulceration and GI bleeding; also had an adenomatous 
polyp of stomach in the past. 
2. INFLAMMATORY FIBROID POLYP : 
45 yr/male, polypoid lesion in fundus of stomach; CT scan – 
suggestive of leiomyoma. Histopathology showed features of 
Inflammatory Fibroid Polyp. 
MULTIPLE LESIONS IN STOMACH: 
1. Two cases of adenomatous polyps with adenocarcinoma 
stomach: 
a) 50 yr female with 1 cm villous adenoma in body of stomach 
with infiltrating moderately differentiated adenocarcinoma 
b) 60 yr female with 1 cm tubulovillous adenoma of antrum 
with infiltrating moderately differentiated adenocarcinoma. 
2. One case of multifocal adenocarcinoma 
3. one case of inflammatory polyp and adenocarcinoma stomach 
4. two cases of hyperplastic polyp and inflammatory polyp 
SMALL INTESTINE: 
TABLE 7 DISTRIBUTION OF POLYPS AND POLYPOID 
LESIONS IN SMALL INTESTINE BASED ON SITE 
 SITE DISTRIBUTION  
DUODENUM 48 (85.72%) 
JEJUNUM 4 (7.14%) 
ILEUM 4 (7.14%) 
TOTAL 56 
 
TABLE 8 DISTRIBUTION OF POLYPS AND POLYPOID 
LESIONS IN SMALL INTESTINE BASED ON HISTOLOGICAL 
TYPE 
POLYPS  NUMBER OF CASES 
Hyperplastic polyp 15 
Inflammatory polyp 2 
Inflammatory fibroid polyp 1 
Peutz-Jeghers polyp 2 
Adenomatous polyp 
Tubular adenoma 
Tubulovillous adenoma 
4 
2 
2 
 
POLYPOID LESIONS NUMBER OF CASES 
Adenocarcinoma 2 
Brunner gland hyperplasia 3 
Chronic duodenitis 3 
Non-specific inflammation 13 
GIST 1 
Pseudopolyp 2 
Carcinoid  1 
Multiple lesions 7 
TOTAL(polyps & polypoid 
lesions) 
56 
 
RARE LESIONS IN SMALLL INTESTINE: 
1. GIST: 40 yr/female, polypoid lesion in duodenum; grossly, 
pedunculated mass measuring 6 cm diameter with 1 cm stalk; cut 
surface – encapsulated, solid, grey white. Microscopy showed 
features of GIST intermediate grade. 
2. PEUTZ-JEGHER’S POLYP: 2 cases: 30 yr/female, ileal polyp 
presented with intussusception ; 35 yr/male, presented with 
melena; found to have jejunal polyp. 
3. PSEUDOPOLYPS: 2 cases: 65 yr male and 65 yr female patients; 
both had duodenal polyps. Microscopic examination showed 
inflammatory pseudopolyps (no past history of Inflammatory 
Bowel Disease). 
4. CARCINOID: 65 yr/ male; carcinoid tumour presented as sessile 
polyp in first part of duodenum (measuring 1cm x 0.5cm x 0.5cm). 
5. INFLAMMATORY FIBROID POLYP: 65 yr/male; ileoileal 
intussusception with ileal polyp (pedunculated,3 cm diameter, with 
stalk 1 cm length); polyp appeared gangrenous; Histopathological 
examination showed features of inflammatory fibroid polyp with 
torsion. 
MULTIPLE LESIONS:  
 Inflammatory polyps duodenum occurring along with 
1.Adenocarcinoma stomach  2.Squamous cell carcinoma 
esophagus. 
 hyperplastic polyp with adenocarcinoma stomach. 
 adenomatous polyp duodenum with adenocarcinoma stomach. 
 
LARGE INTESTINE: 
TABLE 9 DISTRIBUTION OF POLYPS AND POLYPOID 
LESIONS IN THE LARGE INTESTINE BASED ON SITE 
SITE NUMBER OF 
CASES 
CAECUM 24 
COLON 
1. Ascending, Transverse, Descending, 
Sigmoid 
2. Rectosigmoid 
3. Multifocal 
4. Unspecified(Inadequate Data) 
 
94 
 
21 
13 
18 
RECTUM 70 
ANAL CANAL 29 
TOTAL 269 
 
 
 
 
TABLE 10 DISTRIBUTION OF POLYPS AND POLYPOID 
LESIONS IN THE LARGE INTESTINE BASED ON SITE (RIGHT 
VS LEFT COLON) 
RIGHT COLON LEFT COLON 
CAECUM 24 SPLENIC FLEXURE 4 
ASCENDING 
COLON 
13 DESCENDING 
COLON 
26 
HEPATIC 
FLEXURE 
3 SIGMOID COLON 34 
TRANSVERSE 
COLON 
14 RECTUM 
RECTOSIGMOID 
70 
21 
TOTAL 54 
(20.07%) 
TOTAL 159(59.12%) 
 
ANAL CANAL 29 
BOTH RIGHT AND LEFT 
COLON (MULTIFOCAL) 
9 
DATA INADEQUATE 18 
 
LEFT COLON + ANAL LESIONS : 188 (69.89%) 
TABLE 11 DISTRIBUTION OF POLYPS AND POLYPOID 
LESIONS IN THE LARGE INTESTINE BASED ON 
HISTOLOGICAL TYPE  
Polyp/polypoid lesion Number Percentage 
Hyperplastic polyps 42 15.61 
Inflammatory polyps 34 12.63 
Hamartomatous polyps 
a. Peutz jeghers polyp 
b. Juvenile polyp 
c. Retention polyp 
13 
2 
5 
6 
4.83 
Adenomatous polyps 120 44.61 
Mesenchymal polyps 
a. Lipomatous polyps 
b. Fibroepithelial polyp 
c. Angiomatous polyp 
20 
4 
15 
1 
7.43 
Malignancies: 
a. Adenocarcinoma 
b. NHL 
c. Malignant melanoma 
27 
25 
1 
1 
10.04 
Pseudopolyps 11 4.09 
a. Inflammatory 
b. Ulcerative colitis 
7 
4 
Others -Crohn’s disease 2 0.74 
Total 269  
 
TABLE 12 COMPARISON OF MAJOR TYPES OF POLYPS OF 
LARGE INTESTINE (OTHER THAN ADENOMATOUS POLYPS) 
 HYPERPLASTI
C POLYP  
INFLAMMATOR
Y POLYP  
JUVENIL
E POLYP  
TOTAL (%) 42(15.6%) 34(12.6%) 11(4.1%) 
MEAN AGE 51 yrs 46.5 yrs 33.7 yrs 
MALE/FEMAL
E 
6:1 2.8:1 10:1 
LOCATION Caecum – 5 
Right colon – 5 
Left colon – 13 
Rectum – 15 
Anal canal - 4 
Caecum – 7 
Right colon-3 
Left colon – 6 
Rectum – 10 
Anal canal-1 
Data inadequate-7 
Rectum -7 
Sigmoid 
colon-1 
Anal -1 
Hepatic 
flexure-1 
multifocal-
1 
MULTIPLE 
POLYPS 
- 1 1 case 
ASSOCIATED 
CANCERS 
5  
1-anal squamous 
cell carcinoma 
4- 
adenocarcinomas 
(3-rectal 1-
transverse colon) 
2 
Both 
adenocarcinomas 
colon 
None 
 
SYNCHRONOUS LESIONS OF COLON AND STOMACH– 2 CASES: 
 28 yr/ male, Hyperplastic polyp stomach & Tubulovillous 
adenoma colon; 61 yr/male, GIST stomach & Adenocarcinoma Colon 
SYNCHRONOUS LESIONS OF COLON AND SMALL INTESTINE – 
2 CASES: 
19 yr/male, Inflammatory polyps of small and large intestine;       
68 yr/male, chronic lymphocytic duodenitis & hyperplastic polyp of 
transverse colon 
 
TABLE 13 ADENOMATOUS POLYPS OF LARGE INTESTINE 
Poly
p 
No 
Maligna
ncy
 
Malignant 
Features 
Seen 
With Non-
Contiguous 
Cancer 
Associated 
With Other 
Lesions 
Total 
(Percent) 
TA 54 1 5 4 
3- 
inflammation 
1-TB 
64 
(53.33%) 
TVA 25 3 8 2 
1-
Hyperplastic 
polyp 
1-ulcerative 
colitis 
38 
(31.67%) 
VA 11 1 3 1-
inflammation 
16 
(13.33%) 
FA 2    2(1.67%) 
 92(76.7
%) 
5(4.2%) 16(13.3%) 7(5.8%) 120 
TA – Tubular Adenoma; TVA – Tubulovillous Adenoma 
VA – Villous Adenoma; FA – Flat Adenoma 
Totally 5 cases of multiple (more than 100 polyps) adenomatous polyps 
in colon were noted (Table 14). Two of these patients showed malignant 
transformation. No definite positive family history was obtained in these 
patients. 
TABLE 14 ADENOMATOUS POLYPOSIS COLI  
 Age Sex Predominant Type of polyp Malignant 
change 
1. 30 Female Villous adenomas Present 
2. 35 Female Tubulovillous adenomas Present 
3. 39 Male Tubular adenoma Absent 
4. 42 Male Tubular adenoma Absent 
5. 65 Male Tubular adenoma Absent  
 
TABLE 15 POLYPS SHOWING MALIGNANT CHANGE 
AGE/SEX ADENOMA CARCINOMA 
54/F Tubular Poorly differentiated signet ring cell 
carcinoma 
79/M Tubulovillous Well differentiated adenocarcinoma 
70/M Tubulovillous Well differentiated adenocarcinoma 
56/F Tubulovillous Moderately differentiated 
adenocarcinoma 
78/F Villous Well differentiated adenocarcinoma 
 
TABLE 16 DETAILS ABOUT POLYPS WITH CO-EXISTING 
COLONIC CANCERS 
 
ADENO
MA 
ADENOCARCINOMA  
 
TOTAL 
Well 
Differentiated 
Moderately 
Differentiated 
Poorly 
Differentiated 
Tubular 2 3 0 5 
Tubulovill
ous 
3 4 1 8 
Villous 1 1 1 3 
 6(37.5%) 8(50%) 2(12.5%) 16 
 
 
 
 
 
IMMUNOHISTOCHEMISTRY STUDIES: 
TABLE 17 P53 EXPRESSION IN ADENOMATOUS POLYPS, CO-
EXISTING ADENOCARCINOMAS AND CONTROL GROUP 
 P53 positive P53  negative Total 
COMPARATIVE 
POLYPS 
7 (43.75%) 9 (56.25%) 16 
POLYPS WITH 
NEARBY CANCER 
13 (61.9%) 8 (38.1%) 21 
CANCERS 16 (76.2%) 5 (23.8%) 21 
TOTAL 36 22   
 
TABLE 18 CHI SQUARE TEST FOR P53 (COMPARING POLYPS 
WITH AND WITHOUT SYNCHRONOUS CANCERS) 
 CHI-SQUARE 
VALUE 
2 TAILED P 
UNCORRECTED 1.2052 0.2722944784 
MANTEL-HAENSZEL 1.1726 0.2788717700 
CORRECTED 0.5850 0.4443568801 
Chi square value is 0.5850 (p=0.4443), the association between p53 
expression and risk of malignancy in adenomatous polyp is not 
statistically significant. 
TABLE 19 ODD BASED PARAMETERS FOR P53 
 ESTIMATE LOWER UPPER 
ODDS RATIO 2.0893 0.5562 7.8476 
MLE ODDS 
RATIO(MID P) 
2.0470 0.5362 8.1491 
FISCHER-EXACT  0.4622 9.6047 
 
TABLE 20 RISK BASED PARAMETERS FOR P53 
 ESTIMATE LOWER UPPER 
RISK RATIO 1.3813 0.7595 2.5119 
RISK DIFFERENCE 17.9412 -13.6811 49.5635 
 
 
 
 
 
TABLE 21 BCL2 EXPRESSION IN ADENOMATOUS POLYPS, 
CO-EXISTING ADENOCARCINOMAS AND CONTROL GROUP                                                                            
 bcl2 positive bcl2 negative Total 
COMPARATIVE 
POLYPS 
10 (62.5%) 6(37.5%) 16 
POLYPS WITH 
NEARBY CANCER 
15 (71.4%) 6 (28.6%) 21 
CANCERS 6 (28.6%) 19 (71.4%) 21 
TOTAL 31 31  
 
TABLE 22 CHI SQUARE TEST FOR BCL2 (COMPARING 
POLYPS WITH AND WITHOUT SYNCHRONOUS CANCERS) 
 CHI-SQUARE 
VALUE 
2 TAILED P 
UNCORRECTED 0.3304 0.5654493732 
MANTEL-
HAENSZEL 
0.3214 0.5707508900 
CORRECTED 0.0485 0.8256164151 
Chi square value is 0.0485(p=0.8256) hence bcl2 expression is not 
correlated with risk of malignancy in adenomatous polyps. 
TABLE 23 ODD BASED PARAMETERS FOR BCL2 
 ESTIMATE LOWER UPPER 
ODDS RATIO 1.5000 0.3751 5.9978 
MLE ODDS RATIO(MID 
P) 
1.4834 0.3548 6.2657 
FISCHER-EXACT  0.2995 7.4483 
 
TABLE 24 RISK BASED PARAMETERS FOR BCL2 
 ESTIMATE LOWER UPPER 
RISK RATIO 1.2000 0.6264 2.2988 
RISK DIFFERENCE 10.0000 -24.1925 44.1925 
 
 
 
 
 
 
 
 
INCIDENCE: 
 Polyps of gastrointestinal tract have varying incidence depending 
on the site of the lesion. Esophageal polyps are very rare whereas polyps 
in the stomach and colon are relatively common. This study is hospital 
based and does not reflect the true incidence of gastrointestinal polyps. 
Gastrointestinal polyps and polypoid lesions constituted 0.745% of 
biopsies received at the tertiary care center. The majority of lesions are 
situated in the large intestine, constituting 59.53% of cases followed by 
the stomach which constituted 26.55% of cases. The incidence of gastric 
polyps is reported as 0.4% of autopsy cases
58
  and 5% of endoscopic 
studies
59, 9
. Small intestinal lesions, especially ileal polyps are being 
increasingly detected in the early stages due to the advent of new 
endoscopic techniques such as small bowel push endoscopy and video 
capsule endoscopy. Large intestinal lesions have remained the 
predominant population with most of them being adenomatous polyps. 
True incidence of these lesions is lacking.  Table 25 shows a comparison 
of autopsy based studies of large intestinal polyps in various countries.  
 
 
 
TABLE 25 AUTOPSY BASES STUDIES OF LARGE INTESTINAL 
POLYPS 
Study Place Total no.of 
cases  
Predominant 
polyp  
n(%) of total 
Jass JR et 
al
60 
New 
Zealand 
495 Hyperplastic 
polyps 
252(50.9%) 
Williams et 
al
61 
Liverpool 843 Hyperplastic 
polyps 
574(68.1%) 
Rickert 
RR
62 
New Jersey 1023 Adenomatous 
polyp 
658(64.32%) 
Vatn MH
63 
Oslo  445 Adenomatous 
polyp 
329(73.93%) 
Lee YS
64 
Singapore  1,014 Adenomatous 
polyp 
170 (16.8%) 
Tony et al
65 
India 124 Adenomatous 
polyp 
99(79.8%) 
 
As can be noted, the incidence and type of colorectal polyp varies in 
different populations across the world. In our study, adenomatous polyps 
were commonest, almost 2.7 times commoner than hyperplastic polyps.  
PATHOGENESIS : 
The pathogenesis of polyps is reflected in the classification of polyps. 
Hyperplastic polyps arise in a background of chronic inflammation, hence 
they are common in the stomach in the setting of chronic atrophic 
gastritis. Hamartomatous polyps are composed of mixture of mature 
tissues at their indigenous site. Inflammatory polyps arise in a setting of 
chronic cycles of injury and healing, such as in solitary rectal ulcer 
syndrome. Neoplastic polyps may arise de novo or may be a component 
of Familial Adenomatous Polyposis syndromes.  
LESIONS OF ESOPHAGUS : 
 Polyps and polypoid lesions of esophagus are uncommon though 
malignancies are associated with polypoid presentation. In our study, 
three cases showed hyperplastic squamous epithelium and two cases with 
features of Barrett’s esophagus. No malignant polypoid lesions were seen 
in our study. Squamous hyperplasia is considered as early histologic 
manifestation of Gastro-esophageal Reflux disease, even in the absence 
of macroscopic esophagitis
66
. The interpretation of early changes is 
subject to inter and intra-observer variation and also depends on number 
and topography of biopsies and technical aspects. 
 Barrett’s esophagus is defined as endoscopically recognized 
columnar metaplasia of esophageal mucosa which is confirmed 
pathologically by the presence of goblet cells
67
. It is more common in 
males; in our study of two cases, equal incidence was seen and both 
presented with epigastric pain. Endoscopically, the lesion is identified by 
salmon coloured mucosa with focal ulceration or erosion. Dysplasia in 
Barrett’s esophagus presents as flat, nodular or polypoid lesions68 and are 
called as adenomas. In our study, both cases showed intestinal metaplasia 
and no evidence of dysplasia was seen. 
LESIONS OF STOMACH : 
Polyps and polypoid lesions of stomach constitute 26.55% of total 
cases in our study. The age group ranged from 16 yrs to 80 yrs with a 
mean age of 51 yrs. In our study, female patients outnumbered males in 
the ratio 1.2:1. The commonest site of involvement was antrum and the 
commonest lesion was hyperplastic polyp.  
The predominant polyp in our study was hyperplastic polyp. 
Hyperplastic polyps, according to literature, are commonly seen in the 
antrum and reflected in our study also. They present as single or multiple 
lesions- solitary lesions were common in our study. Grossly they appear 
as oval elevations of mucosa with smooth contours. They may be sessile 
or pedunculated, sessile lesions constituting 93.5% of cases in our study. 
One polyp of size 1.5 cm was associated with gastric outlet obstruction. 
Rare cases of hyperplastic polyp simulating hypertrophic pyloric stenosis 
in pediatric age group
69
 and  causing gastric outlet obstruction in an adult 
female patient
70
 have been reported. Histologically, hyperplastic polyps 
showed hyperplastic and elongated foveolae with corkscrew appearance, 
lined by columnar epithelium and cystically dilated glands with mild to 
moderate inflammation in the stroma. Some polyps also showed intestinal 
metaplasia and duct-like structures with cuboidal epithelium and 
eosinophilic granular cytoplasm. Two cases of hyperplastic polyps co-
existing with inflammatory polyps were seen in our study. The incidence 
of malignancy in hyperplastic polyps is reported to range from 1.5% to 
4.5%
71,72
. No cases of hyperplastic polyposis or hyperplastic polyps co-
existing with carcinoma stomach were seen in our study, showing that 
malignant transformation of hyperplastic polyps are very rare. The 
significance of identifying hyperplastic polyps lies in identifying 
associated gastric pathology. 
Inflammatory polyps constituted 10.6% of gastric polyps. Fundic 
gland polyps and inflammatory fibroid polyps were seen in less numbers. 
Adenomatous polyps constituted 13.6% with 2 of them in female patients 
associated with infiltrating adenocarcinoma of stomach. 
LESIONS OF SMALL INTESTINE: 
 Small intestinal polyps are being increasingly detected using 
various techniques such as capsule endoscopy and single/double balloon 
endoscopy. Various studies have shown different distribution of polyps. 
Most of the previous studies of small intestinal polyps are confined to the 
duodenum or the distal ileum due to lack of investigative modalities to 
access the entire small intestine. The predominant site of involvement in 
this study was the duodenum, constituting 85.72% of cases of small 
intestine. Hyperplastic polyps were the most common, followed by 
inflammatory polyps. 2 cases of Peutz-Jeghers polyps were recorded. 
Hyperplastic polyps were all seen in the duodenum. A large Japanese 
study
73
 showed that 15 out of 25 lesions seen in duodenum were 
Hyperplastic polyps. In our study, all the patients with hyperplastic 
polyps were males, with one female patient in whom, it was seen as a 
verrucous polypoid lesion. The youngest age of presentation was 17 yr 
male patient who had presented with acute small bowel obstruction and 
incidentally, a hyperplastic polyp was found in the resected gangrenous 
segment of bowel. This study shows a possible younger age of onset of 
hyperplastic polyps and predominance in males. 
 Peutz-Jeghers polyps may be sporadic or syndromic, with sporadic 
cases reported in various sites such as duodenum
74
, stomach
75
, jejunum
76
 
and rectum
77
. Peutz Jeghers syndrome is defined by the following criteria: 
(a) three or more histologically confirmed Peutz-Jeghers polyps (b) any 
number of Peutz-Jeghers polyps with a family history (c) characteristic 
mucocutaneous pigmentation with a family history or (d) any number of 
Peutz-Jeghers polyps and characteristic mucocutaneous pigment. PJ 
polyps are the commonest hamartomatous polyps of the small intestine, 
with majority in the jejunum, followed by ileum and duodenum. Solitary 
or multiple, they present with GI bleed, anemia, abdominal pain and 
recurrent intussusception. In our study, PJ polyps of small intestine were 
rare, only two cases were seen : a 30 yr old female patient who had ileal 
PJ polyp and presented with intussusception and a 35 yr male patient with 
jejunal PJ polyp who had melena. As noted, both were in 4
th
 decade and 
symptomatic. No features of Peutz Jeghers syndrome were seen. The 
existence of sporadic PJ polyps has been questioned as they have been 
associated with development of carcinoma at other sites during follow up 
studies
78
. 
 
 
LESIONS OF LARGE INTESTINE: 
The predominant population of colonic polyps in this study was formed 
by adenomatous polyps(44.61% of colonic polyps). Of these, 53.3%(64) 
were tubular adenomas which are the commonest type of colonic polyps 
as seen in other studies also (TABLE 26). 
TABLE 26 VARIOUS STUDIES OF ADENOMAS OF LARGE 
INTESTINE 
AUTHOR 
LOCATIO
N 
Tubular 
adenoma 
Tubulo- 
villous 
adenoma 
Villous 
adenoma 
(A) (B) (C) 
Rahat N et 
al
79 
KARACHI 
10 
(55.55%) 
3 
(16.67%) 
5 
(27.78%) 
1 
(5.6%) 
- 18 
Ali Zare 
Mirzaie et 
al
80 
IRAN 
121 
(69.94%) 
24 
(13.87%) 
28 
(16.18%) 
- - 173 
Nouraie et 
al
81 
AFRICAN-
AMERICA
N 
3641 
(86.57%) 
414 
(9.84%) 
151 
(3.59%) 
- - 420
6 
Tony J et 
al
65 
INDIA 
67 
(68%) 
24 
(24%) 
14 
(14%) 
6 
(6.06%
) 
1 
(1.01%
) 
99 
A Khan et 
al
82 
CANADA 
566 
(65%) 
225 
(25.8%) 
63 
(7.2%) 
12 
(1.4%) 
 871 
Present 
study 
INDIA 
64 
(53.33%) 
38 
(31.67%) 
16 
(13.33%) 
5 
(4.2%) 
16 
(13.33
%) 
120 
(A) – polyps showing malignancy (invasion across muscularis 
mucosa);  
(B)  – polyps associated with synchronous non-contiguous 
malignancy; 
(C)  – total cases studied 
The mean age of colonic adenomatous polyps (49 yrs) is lesser 
than that of another South Indian study in which the same is 58.1 yrs. The 
male female ratio and type distribution are similar. The type distribution 
is similar to other studies worldwide as shown in table 26 , tubular 
adenomas being the commonest followed by tubulovillous adenomas with 
the exception of two studies(Karachi and Iran) in which villous adenomas 
are more common than tubulovillous adenomas. The size of the polyps 
were not available for all cases in the present study and hence was not 
analysed. 2 cases of Flat adenomas which endoscopically showed raised 
mucosa resembling tiny polypoid lesions were noted. Microscopically 
only adenomatous changes with no infiltration were seen. 
5 cases of adenomatous polyposis coli were noted in which entire 
colon was studded with more than 100 polyps. These patients belonged to 
a wide age range from 30 yrs to 65 yrs. Notably, all were in late 
adulthood and no positive family history was obtained. Two of these 
patients showed malignant transformation.  Familial adenomatous 
polyposis presents in childhood or adolescent or early adulthood with 
thousands of polyps in colon as well as in other parts of gastrointestinal 
tract. By definition more than 100 polyps should be present. Genetic 
studies in FAP show loss of both copies of APC gene on chromosome 5q. 
Proctocolectomy was done in these 5 cases. 
ADENOMATOUS POLYPS WITH MALIGNANT CHANGES AND 
NON-CONTIGUOUS MALIGNANCIES: 
 A malignant adenomatous polyp by definition shows malignant 
epithelium invading across muscularis mucosa
83,84,85
. The incidence of 
malignant change in adenomatous polyps varies from 1.4% in Canada to 
6.06% in South India. The proportion of such polyps in our study (4.2%) 
is similar to Tony et al and is higher than those of Western studies. 
 16 cases (13.33%) showed presence of adenomatous polyps and 
non-contiguous colonic cancers. The age range is variable from 22 yrs to 
70 yrs; males were more commonly affected. The predominant lesions 
were left sided. All the three types of adenomatous polyps are found to be 
associated with cancers. All three grades of Cancer were also noted to be 
associated with polyps. 
 This study shows a higher percentage of adenomatous polyps co-
existing with colonic cancers when compared to other Indian as well as 
Western studies. The incidence of adenomatous polyps parallels the 
incidence of Colonic cancers. Adenomas are considered as 
epidemiological indicators of increased risk of cancers. Western studies 
show a high colonic cancer incidence(United States – male : 40.6 females 
: 30.7 per 1,00,000 population) when compared to India(males : 4.7 
females : 3.2 per 1,00,000 population) as per GLOBOCAN 2000 data
34
. 
The current study has covered the period of 2008 to 2012, which 
indicates that incidence of adenomatous polyps in this part of India is 
increasing and also suggests an increasing trend in the incidence of 
colonic cancer, especially left sided colonic cancers. 
 The second major population in this study was hyperplastic polyps 
which constituted 15.6% cases. The average age is 51 yrs similar to that 
in literature. Hyperplastic polyps of large intestine are uncommon before 
the fifth decade
60
 
 
and are seen more commonly in the rectum and 
sigmoid colon. Left sided lesions were more common in this study 
(69.89%) when compared to right sided lesions (20.07%). A male 
predominance was also seen.  
According to various studies, hyperplastic polyps are 
 1) possibly neoplastic lesions due to demonstration of k-ras mutations 
and clonal changes involving chromosome 1 which is also seen in 
adenomas  
2) more commonly associated with adenomas  
3) presence of distal hyperplastic polyp indicates risk for proximal 
adenoma (debated)  
4) share the same risk factors as for adenomas and carcinomas.  
However, in this study, 
1) adenomas were three times commoner than hyperplastic polyps 
2) no cases of both types of colonic polyps were recorded in the same 
patient  
3) 5 cases(11.9%) out of 42 cases co-existed with large intestinal cancers. 
  These results indicate that hyperplastic polyps are less common 
when compared to adenomatous polyps in this part of the country and do 
not serve as indicator for presence of adenomas. The definite role of 
hyperplastic polyps in colonic cancers requires molecular studies even 
though 11.9% of hyperplastic polyps showed association with cancer. 
 12.6% of colonic polyps were inflammatory polyps. 11 cases 
(4.09%) were pseudopolyps of which 7 were non-specific inflammatory 
origin and 4 were associated with Inflammatory Bowel Disease.  
 Hamartomatous polyps constituted 4.83% (11 cases) of large 
intestinal lesions in this study. Of these, 2 cases were Peutz-Jeghers 
polyps while remaining 11 cases were juvenile polyps. Juvenile polyps 
were solitary sporadic lesions in our study except for one case in which it 
was multiple. The remaining 10 patients showed predominant 
involvement of left colon, especially rectum. Juvenile polyps are 
commonly seen in the paediatric age group, but also reported in adults, 
with the incidence beyond 20 yrs reported between 0 and 40%
86
. They 
present with usually with melena. Similar to other studies, there were no 
colonic malignancies associated with juvenile polyps in this study. 
P53 AND BCL2 IN COLORECTAL ADENOMATOUS POLYPS AND 
THEIR RELATION TO CANCER: 
 Various individual studies of p53 and bcl2 expression in colorectal 
polyps and cancers have been done. Results have been consistent with 
p53 and more variable with bcl2. Shanmugam et al
56 
have studied the 
expression of p53 and bcl2 in normal colonic epithelium, contiguous 
colorectal adenomas and cancers and found that expression of p53 and 
Bcl-2 progressively increased from normal-appearing epithelium to 
adenomas to carcinomas. They also concluded that the presence of p53 in 
the adenomatous epithelium is an indicator of aggressive behavior of 
colonic lesions, and that these patients are more likely to develop 
aggressive invasive cancer.  
In the current study, the expression of p53 also shows similar 
progressive increase from adenomatous polyps without synchronous 
colonic malignancy to those with synchronous malignancies to frank 
colonic malignancies. However, the difference between p53 expression in 
adenomatous polyps with and without synchronous malignancies has not 
been statistically significant. This could be possibly due to the small 
sample size in both the groups. A higher proportion of adenomatous 
polyps with synchronous colonic malignancies have shown p53 
expression than those without synchronous malignancies(61.9% vs. 
43.75%). The progressive increase in p53 expression has been noted in 
other human studies and  has been proved in animal models but may be 
difficult to prove directly in humans as most polyps detected during 
endoscopy are removed by polypectomy. However, the increased 
expression of p53 can serve as an indication for placing such patients 
under high risk group with need for surveillance. Considering these 
findings, the time span for progression of an adenoma to carcinoma and 
the use of p53 as a predictive marker for malignancy in an adenomatous 
polyp requires more extensive research. 
Bosari et al
46 
found diffuse bcl2 positivity in all colorectal 
adenomas and negative in 50% colorectal cancers. He also found that 
bcl2 expression was not correlated with p53 expression and had no 
prognostic significance. The expression of bcl2 has been variable in this 
study, with maximum expression in polyps associated with cancers than 
in cancers themselves or the comparative group of polyps. Mutations in 
p53 and expression of bcl2 in mature epithelium (which is abnormal) 
both favour the abnormal cells to survive. The different expressions of 
bcl2 in the three groups in this study indicate possible interactions 
between bcl2 and other genes involved in carcinogenesis. Table 27 shows 
the various results of bcl2 expression in various studies. 
TABLE 27 BCL2 EXPRESSION IN ADENOMATOUS POLYPS 
AND COLORECTAL CARCINOMAS IN VARIOUS STUDIES 
Author Bcl2 in adenomatous 
polyps – proportion of 
cases positive 
Bcl2 in cancers -  
proportion of cases 
positive 
Bosari et al
46 
100%   50%  
Nakamura et al
87 
80%  30% 
Husain A Saleh et al
88 
51.9% 78.6% 
Nigel Scott et al
89 
95% 35% 
 
   Studies show bcl-2 expression is seen in various pre-malignant 
and malignant lesions. Hence, it is suggested that bcl-2 genetic alterations 
are seen early in the pathway of carcinogenesis. bcl 2 expression is said to 
have a favorable prognosis in breast and lung carcinomas and unfavorable 
in prostate carcinoma
90
. bcl-2 expression in colorectal carcinomas is 
found to be associated with a better clinical course especially in the 
absence of  p53 expression indicating that neoplasia caused by inhibition 
of apoptosis may cause less aggressive malignancies than those caused by 
other oncogenes like p53 and K-ras
46,91,92
. An inverse relationship has 
been noted between bcl-2 and p53 expression in many malignancies, 
suggesting that these proteins may interact through opposite mechanisms: 
inhibition of apoptosis (bcl-2), and promotion of apoptosis (p53)
92,93
. 
 
 
 
 
 
 
 
 
 
 
 
 
 
STRENGTHS AND LIMITATIONS OF THE STUDY: 
STRENGTHS : 
1. The study analyses a large number of cases received at a tertiary 
care centre in the country. 
2. All types of polyps and polypoidal lesions of gastro-intestinal tract 
are analyzed. 
3. Important genetic markers have been studied in both pre-malignant 
and malignant lesions. 
4. The genetic markers studied include bcl2 and p53, whose roles in 
adenoma-carcinoma sequence are respectively in early and late 
stages. Hence both early and late changes are studied with respect 
to the two genes. 
LIMITATIONS : 
1. The study is hospital based; so true incidence and prevalence in the 
community is not known. 
2. Clinical details namely symptoms and size of polyp were not 
available in all cases and not analyzed. 
3. Follow-up of patients is not analyzed. 
 
 Polyps and polypoid lesions of gastro-intestinal tract constitute  
0.745% of all specimens submitted for histopathological examination  at 
a tertiary care centre over four and a half  year period. 
 Majority of cases involved the large intestine constituting 59.53% 
of total. 
 The second commonest site of involvement was the stomach 
(26.55%). 
 The age group ranged from 13 yrs to 88 yrs. 
  A male predominance was noted in all the sites except for stomach 
where females outnumbered males. 
 The esophageal lesions were commonest at the lower end of 
esophagus and were predominantly changes of GERD; Barrett’s 
esophagus was also seen.  
 The stomach lesions were commonly hyperplastic polyps seated at 
the antrum. Rarer polypoid lesions encountered in the stomach include 
GIST and inflammatory fibroid polyp. 
 Duodenum was the predominant site of involvement in the small 
intestine (85.72%). Hyperplastic polyps were the commonest polyps seen. 
  Other less frequent lesions seen in the small intestine were 
Gastrointestinal stromal tumour, pseudopolyps, carcinoid, inflammatory 
fibroid polyp (presented with torsion and intussusception) and Peutz-
Jeghers polyp (presented with intussusception). 
 Maximum number of lesions were seen in the colon, especially left 
colon (59.12%) with the rectum being the commonest site. 
 Adenomatous polyps constituted the bulk of large bowel polyps 
(44.61%).  
 Hyperplastic polyps were the second commonest (15.71%). 
 Among the adenomatous polyps, tubular adenomas constituted 
53.33%, tubulovillous adenomas – 31.67%, villous adenomas – 13.33%. 
 Adenomatous polyps were seen in a wide age group of 22 yrs to 70 
yrs. 
 5 cases of adenomatous polyps showed malignant change (4.2%). 
 5 cases showed multiple (more than 100) adenomatous polyps 
involving the large intestine. They were in the 4
th
 to 7
th
 decade; 2 of them 
showed malignant transformation. 
 16 cases of adenomatous polyps (13.33% of adenomatous polyps) 
were associated with non-contiguous colonic cancers which is much 
higher than other studies worldwide. 
 P53 expression was found to be higher in polyps with contiguous 
or non-contiguous malignancies (61.9%) than in polyps without them 
(43.75%). They were much higher in the co-existing cancers (76.2%). 
 However, P53 expression was not significantly correlated with risk 
of malignancy in adenomatous polyps (p=0.5850). 
 Bcl2 expression was found to be variable in the three groups and 
was not significantly correlated with adenomatous polyps with co-
existent cancers(p=0.825). 
 
 
 
 
 
 
 
 
 
Polyps and polypoid lesions in the gastrointestinal tract may vary 
from asymptomatic incidental findings and benign harmless lesions to 
invasive malignancies. Various investigatory modalities are being 
developed and available in developing countries for screening and 
diagnosis of these lesions. The morphology of the polyps are well defined 
to delineate them from one another. A careful study of adenomatous 
polyps is needed in view of potential for malignant transformation. This 
study finds a high incidence of colonic adenomatous polyps with 
synchronous colonic malignancies. The study is hospital-based and may 
not represent the true incidence of the disease in the community. Hence, 
community based studies are essential to assess the prevalence and risk 
factors for adenomatous polyps. Though surveillance programs have been 
framed, it is imperative to establish cost effective screening guidelines so 
as to detect the lesions earlier. As most of the lesions are left-sided they 
would be more accessible with colonoscopy techniques. Genetic studies 
are needed to establish predictive and prognostic markers for malignant 
transformation of adenomatous polyps. Future studies should be 
community-based with assessment of possible etiological and/or risk 
factors. 
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HYPERPLASTIC POLYP 
  Fig.1  
 
 
 
 
 
 
Elongated dilated and serrated crypt architecture. H & E Fig 1. x10. Fig 2. X40 
 
 Fig. 2 
 
 
 
 
 
 
INFLAMMATORY FIBROID POLYP 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig.  3 Loose edematous lamina propria showing blood vessels and 
inflammatory cells.  H & E x10 
Fig. 4 Glands surrounded by myxoid lamina propria containing capillaries 
admixed with eosinophils and lymphocytes. H & E x40 
JUVENILE POLYP 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 5 Large dilated cysts, some filled with mucin.  H & E x10 
Fig. 6 Dilated crypts separated by an expanded lamina propria showing 
edema, hemorrhage and inflammatory cells. H & E x40 
PEUTZ-JEGHERS POLYP 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 7 & 8. PJ polyp. Externally (Fig 7) lobulated grey-white polyp.          
Cut surface (Fig 8) shows splaying of muscular layer. 
Fig. 7 
Fig. 8 
PEUTZ-JEGHERS POLYP 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 9 
Fig. 10 
Fig.9 & 10 PJ polyp. Shows splayed muscularis mucosae covered by 
normal-appearing epithelium. H & E x10 
TUBULAR ADENOMA 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 11 More than 80% of mucosa showing tubular glands lined by 
dysplastic epithelium. H & E x10 
VILLOUS ADENOMA 
Fig. 12 Mucosa showing finger-like processes of glands lined by 
dysplastic epithelium. H & E x10 
TUBULOVILLOUS ADENOMA 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 13 Resected portion of large intestine with a pedunculated polyp arising 
from the mucosa 
Fig. 14 Mucosa showing glands in villous and tubular pattern lined by 
dysplastic epithelium.         H & E x10 
DYSPLASIA 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 15 Adenoma with low grade dysplasia – elongated crowded hyperchromatic 
nuclei with preserved polarity and mucin secretion. H & E x40 
Fig. 16 Adenoma with high grade dysplasia–irregular glands with nuclei 
showing loss of polarity, prominent nucleoli, mitosis and loss of mucin 
secretion. H & E x40 
P53 EXPRESSION IN ADENOMATOUS POLYP 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 17 Adenomatous polyp showing strong positivity for p53.  x10 
Fig. 18 p53 nuclear staining - strong positivity. x40 
BCL 2 EXPRESSION IN ADENOMATOUS POLYP 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Fig. 20 bcl2 cytoplasmic staining – internal control (mantle zone 
lymphocytes) and adenomatous epithelium show strong positivity. x10 
Fig. 19 bcl2 staining – diffuse strong positivity in adenomatous 
epithelium x10 
ADENOMATOUS POLYPOSIS COLI WITH SYNCHRONOUS 
MALIGNANCY 
 
 
 
 
 
 
 
 
Fig. 21, 22, 23 Multiple Colonic Adenomatous Polyps with ulcerated solid 
infiltrating growth of colon. 
Fig. 21 Fig. 22 
Fig. 23 
ADENOMATOUS POLYP WITH INVASION INTO MUSCULARIS 
MUCOSA 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
Fig. 24 Villous adenoma with invasion into muscularis mucosa (malignant 
transformation) H & E x10 
ANNEXURE Ӏ 
PROFORMA 
CASE NUMBER :      HPE NUMBER : 
NAME :      OP/IP NUMBER :                                     
AGE  : 
SEX  : 
CLINICAL DIAGNOSIS : 
SYMPTOMS : 
ENDOSCOPY FINDINGS : 
 SESSILE/PEDUNCULATED : 
 NUMBER OF LESIONS : 
 SITE: 
 SIZE: 
GROSS FEATURE : 
MICROSCOPY (TYPE) : 
ASSOCIATED CANCERS IF ANY : SITE : 
      TYPE: 
 
ANNEXURE II 
IMMUNOHISTOCHEMISTRY PROCEDURE 
 
PREPARATION OF SLIDES: 
 
1. Sections of 4 micron thickness were cut from formalin fixed paraffin 
embedded tissue specimens and transferred to gelatin-chrome alum 
coated slides. 
2. The slides were incubated overnight at 58ºC. 
3. The sections were then deparaffinized in xylene for 15 minutes x 2 
changes. 
4. Dehydration of sections was done with absolute alcohol for 5 minutes x 
2 changes. 
5. The sections were then washed in tap water for 10 minutes. 
6. The slides were immersed in distilled water for 5 minutes. 
ANTIGEN RETRIEVAL: 
7. Heat induced antigen retrieval was done with microwave oven in 
appropriate temperature with Citrate buffer for 20 minutes. 
8. The slides were then cooled to room temperature and washed in running 
tap water for 5 minutes. 
9. The slides were then rinsed in distilled water for 5 minutes. 
10. Wash with appropriate wash buffer (phosphate buffer) for 5 minutes x 2 
changes. 
BLOCKING STEPS: 
11. Apply peroxidase block over the sections for 10-12 minutes. 
12. Wash the slides in phosphate buffer for 5 minutes x 2 changes.  
13. Cover the sections with power block for 15 minutes. 
 
APPLICATION OF ANTIBODY AND LABELS: 
14. The sections were drained (without washing) and appropriate primary 
antibody was applied over the sections and incubated for 45 minutes. 
15. The slides were washed in phosphate buffer for 5 minutes x 2 changes. 
16. The slides were covered with SuperEnhancer for 30 minutes. 
17. The slides were washed in phosphate buffer for 5 minutes x 2 changes. 
18. The slides were covered with SS Label for 30 minutes. 
19. Wash in phosphate buffer for 5 minutes x 2 changes. 
APPLICATION OF CHROMOGEN AND COUNTERSTAIN: 
20. DAB substrate was prepared by diluting 1 drop of DAB chromogen to 1 
ml of DAB buffer. 
21. DAB substrate solution was applied on the sections for 8 minutes. 
22. Wash with phosphate buffer solution for 5 minutes x 2 changes. 
23. The slides are washed well in running tap water for 5 minutes. 
24.  The sections were counterstained with Hematoxylin stain for 2 seconds 
(1 dip). 
25. The slides are washed in running tap water for 3 minutes. 
26. The slides are air dried, cleared with xylene and mounted with DPX. 
 
 
 
 
 
 
 
SL.
NO 
BIOPSY 
NO 
AG
E 
SE
X 
S/
P SIZE SITE SUB-SITE HPE 
CLINICA
L 
DETAILS 
1 303/08 43 M 
  
Duodenum 
 
Hyperplastic polyp 
 
2 387/08 53 M 
  
Colon 
 
Tubular adenoma 
 
3 536/08 43 M 
  
Duodenum D1 D2 Brunner gland hyperplasia 
 
4 876/08 55 M 
  
Rectum 
 
Inflammatory pseudopolyp 
 
5 977/08 26 M S  
 
Duodenum Bulb Hyperplastic polyp 
 
6 952/08 53 M 
 
1x0.5x0.
5cm Colon 
 
Mucinous adenoca ,tubulovillous 
adenoma 
 
7 1021/08 30 M 
  
Colon Transverse Pseudopolyp with non-spec ulcer 
Ulcerated 
circumfere
ntial 
stricture 
with polyp 
8 1444/08 22 M 
 
2.5x2x1 
cm Rectum 
 
Tubular adenoma 
 
9 1511/08 25 F 
  
Colon Sigmoid Tubular adenoma 
 
10 1616/08 51 F 
  
Rectum 
 
Tubular adenoma 
 
11 1618/08 61 M 
  
Rectum 
 
Tubular adenoma  
 
12 1685/08 33 M 
 
Multiple  Duodenum D2 Non spec inflammation 
Multiple 
nodular 
polypoidal 
lesions in 
d2,dj 
flexure 
13 1686/08 25 M S 1 cm Rectum 
 
Tubular adenoma 
 
14 1831/08 25 F 
  
Colon Sigmoid Tubular adenoma 
 
15 2251/08 60 F 
  
Rectum 
 
Non-spec inflammation 
 
16 2332/08 35 M S 
 
Stomach Antrum Hyperplastic polyp 
 
17 2601/08 60 M 
  
Duodenum 
 
Hyperplastic polyp 
 
18 2699/08 40 F 
  
Duodenum 
 
GIST-intermed grade 
 
19 2735/08 40 F 
  
Colon Transverse Tubulovillous adenoma  
 
20 2820/08 65 M 
  
Rectum 
 
Villous adenoma 
 
21 2913/08 60 M 
  
Stomach Body Hyperplastic polyp  
 
22 2985/08 39 F 
  
Stomach 
Lesser 
curvature Hyperplastic polyp 
 
23 3047/08 19 M 
  
Duodenum 
 
Hyperplastic polyp 
 
24 3513/08 14 M 
  
Rectum 
 
Inflammatory polyp 
 
25 3541/08 55 M 
 
0.2 - 2 
cm Colon r+l Throughout 
CA rectum,adenoca well diff 
papillary, tubulovillous adenoma 
 
26 3603/08 21 M 
  
Rectum 
 
Juvenile polyp 
 
27 3615/08 71 M 
  
Caecum 
 
Hyperplastic polyp 
Intestinal 
obstruction 
28 3924/08 30 F S 
 
Stomach Antrum 
Adenoca infiltr  well diff 
intestinal type 
 
29 3925/08 42 M 
  
Duodenum Bulb Hyperplastic polyp 
 
30 4272/08 50 F 
  
Duodenum D2 Hyperplastic polyp 
Verrucous 
polypoidal 
lesion 
31 4374/08 48 M S 
 
Colon 
Mid descending  
colon Tubular adenoma 
 
32 4377/08 13 M 
  
Rectum 
 
Juvenile polyp 
 
32 4375/08 35 F S 
 
Stomach Antrum Tubulovillous adenoma 
 
34 4450/08 50 F 
  
Duodenum 
 
Tubulovillous adenoma   
 
35 4740/08 65 M 
  
Duodenum D2 Inflammatory pseudopolyp 
 
36 4742/08 38 M P  1 cm Rectum 
 
Juvenile polyp 
 
37 4858/08 43 F 
  
Stomach Antrum Adenoca  infiltr well diff 
 
38 4876/08 40 F S 
 
Stomach Body Non spec inflammation 
 
39 4878/08 58 M 
  
Rectum 
 
Hyperplastic polyp 
 
40 5080/08 60 F P 
 
Anal Anal verge Villous adenoma 
 
41 5107/08 30 F 
  
Stomach Body Chronic gastritis 
 
42 5227/08 37 F 
 
5 mm Rectum Lower rectum Hyperplastic polyp 
Bleeding 
pr 
43 5240/08 38 F 
  
Stomach Antrum Villous adenoma 
 
44 5322/08 59 M 
 
2.5 cm Stomach Lc Tubulovillous adenoma 
 
45 5550/08 35 M 
  
Duodenum D2 & d3 Hyperplastic polyp 
 
46 5741/08 35 M 
  
Anal  
 
Fibroepithelial polyp 
 
47 5754/08 65 M 
  
Stomach Fundus Hyperplastic polyp 
 
48 5755/08 59 M 
  
Stomach Body Hyperplastic polyp 
 
49 5850/08 56 F 
  
Stomach Lc Chronic non specific gastritis 
 
50 5874/08 31 M 
  
Stomach Antrum Chronic lymphocytic gastritis 
 
51 5876/08 47 M 
  
Stomach Pylorus Chronic lymphocytic gastritis 
 
52 5879/08 35 F 
  
Stomach Antrum Hyperplastic polyp 
 
53 5880/08 55 F 
  
Stomach Antrum Hyperplastic polyp  
 
54 5882/08 58 F P 
 
Stomach Pylorus Tubular adenoma 
 
55 6053/08 50 F 
  
Stomach 
A. Pyloric 
growth 
b.polypoidal gr 
incisura 
(a)infiltr adenoca mod diff (b)well 
diff adenoca papillary type 
 
56 6062/08 88 M S 
 
A.growth ogj 
b.polyp duodenum Bulb 
(a) adenoca well diff (b)chronic 
lymphocytic duodenitis with 
superficial ulceration 
 
57 6150/08 43 M 
  
Rectum 
 
Hyperplastic polyp 
 
58 
6227/08 
cr 
4858/08 43 F 
  
Stomach Antrum 
Chronic lymphocytic gastritis & 
few dysplastic glands- s/o early 
gastritic ca 
 
59 6301/08 40 M 
  
Colon Transverse Hyperplastic polyp 
 
60 6302/08 65 M 
  
Colon Recto sigmoid Non spec inflammation 
 
61 6307/08 70 M 
  
Stomach Pylorus Inflammatory polyp 
 
62 6387/08 40 M 
  
Stomach Antrum Hyperplastic polyp 
 
63 6739/08 47 M 
  
Colon Descending Tubular adenoma 
 
64 6742/08 45 M S 
 
Stomach  Pylorus Chronic lymphocytic gastritis 
 
65 6751/08 55 F P 
 
Stomach Antrum Hyperplastic polyp 
 
66 6787/08 38 M S 
 
Duodenum Bulb Chronic lymphocytic duodenitis 
 
67 6959/08 50 M 
S,
p 
2x2x2, 
<0.5 cm Colon Desc & sigmoid 
Tubulovillous adenoma c cystic 
dilatation of glands 
Multiple 
colonic 
polyps 
68 
6964/08 
cr 
6053/08 50 F 
  
Stomach 
 A.ulcer 3*2cm 
b.polyp 1cm 
A.infiltr adenoca intestinal type 
mod diff.  
B.villous adenoma c dysplastic 
changes 
Chronic 
lymphocyti
c gastritis 
69 6984/08 32 F 
  
Stomach Antrum Gastritis c dysplastic glands 
 
70 6997/08 60 M 
  
A)duodenal polyp 
b)growth stomach 
 
A-inflammed hyperplastic polyp 
b-infiltr adenoca well diff 
 
71 7104/08 65 F 
  
Stomach Fundus Fundic gastric polyp 
 
72 7226/08 48 M 
  
Stomach Fundus Fundic gastric polyp 
 
73 7471/08 74 F S 
 
Duodenum 
 
Chronic lymphocytic duodenitis  
 
74 7480/08 50 M S 
 
Colon Sigmoid Hyperplastic polyp 
 
75 7609/08 60 F 
  
Stomach Fundus Chronic lymphocytic gastritis 
 
76 7893/08 25 F 
  
Duodenum D2,D3 Chronic lymphocytic duodenitis  
 
77 8229/08 28 M 
  
Rectum 
 
Inflammatory polyp 
 
78 8255/08 55 M S 6x4cm Rectum 
 
Infltr adenoca well diff 
 
79 8307/08 45 F 
  
Stomach Antrum Hyperplastic polyp with ulcer 
 
80 8478/08 16 F 
 
3-5 mm Stomach Antrum Tubular adenoma 
 
81 8483/08 34 F 
  
Colon 
 
Tubulovillous adenomas 
 
82 8486/08 50 M 
  
Colon Sigmoid Tubular adenoma 
 
83 8548/08 55 M 
  
Colon Sigmoid Tubulovillous adenomas 
 
84 8550/08 48 M 
  
Stomach Body Chronic lymphocytic gastritis 
 
85 8609/08 38 M 
  
Rectum 
 
Pseudopolyp 
 
86 
8667/08 
cr 
8486/08 56 M 
  
Rectum 
 
Lipomatous polyp 
Polyp 
presenting 
with 
intussuscep
tion 
87 8833/08 42 M 
  
Stomach Antrum 
Infiltr adenoca well diff intestinal 
type  
 
88 8888/08 30 M 
  
Rectum 
 
Adenoca infilt  well diff 
 
89 8892/08 30 F S 
 
Stomach GC Chr lympho gastritis 
K/c men 
2b with 
multiple 
polyps 
hypophary
nx,stomach 
90 8948/08 44 F 
  
Colon r+l 
A.caecum, right 
colon b. Left 
colon 
A)non spec inflammation b)infiltr 
adenoca well diff 
 
91 9014/08 26 M 
  
Colon Splenic flexure Hyperplastic polyp 
C/o 
constipatio
n 
92 9022/08 60 M S 
 
Colon r+l 
A.asc colon 
b.sigmoid colon 
polyp 
A.infiltr adenoca well diff b.infiltr 
adenoca papillary type 
 
93 9023/08 42 F S 
 
Colon Transverse 
Tubular adenoma c  mild 
dysplasia 
 
94 27/2009 56 M 
  
Rectum 
 
Hyperplastic polyp c foci of 
adenomatous change 
 
95 30/2009 65 F S 
 
Stomach 
A.growth 
stomach b. 
Polyp antrum A-adenoca mod diff b-adenoma 
 
96 
149/09 
cr 
8948/08 44 F 
  
Colon+rectum 
A.growth 
sigmoid c b.4 
pedunc ,4 
sessile polyps 
rectosigmoid c 
A.infiltr mod diff adenoca 
b.pedunc-tubular adenoma 
sessile-hyperplastic polyp 
Multiple 
polyps 
throughout 
colon 
97 186/09 55 M 
  
Duodenum D2 Inflammatory polyp 
 
98 187/09 61 M 
  
Duodenum D2 Hyperplastic polyp 
 
99 222/09 60 M 
  
Stomach Antrum Hyperplastic p 
 10
0 441/09 19 M 
  
Duodenum D2,D3 Chronic duodenitis 
 
10
1 517/09 44 M 
  
Rectum 
A.bx prox 
rectum b.large 
polypoidal 
lesion distal 
rectum 
A)mod diff adeno ca 
b)hyperplastic polyp 
 10
2 555/09 30 M P 
 
Colon Sigmoid Lipomatous polyp 
 10
3 579/09 58 F 
  
Stomach Fundus Chronic gastritis 
 10
4 599/09 56 M P 
 
Stomach Body Adenoca infilter mod diff  
 10
5 604/09 53 F S 
 
Duodenum D2 Chronic inflammation 
 10
6 655/09 62 N S 5 cm Rectum 
 
Inflammatory polyp 
 
10
7 661/09 70 M 
  
A.duodenal 
polyp,b.growth 
esophagus 
 
A-inflamm polyp b-mod diff scc 
 10
8 662/09 55 M 
  
Colon 
 
Villous adenoma c low grade 
dysplasia 
 
10
9 710/09 45 M 
  
Caecum+colon 
A-unhealthy 
mucosa in desc 
colon b-polyp 
in cecum & asc 
colon 
A)adenomatous changes 
b)tubulovillous adenoma c low 
grade dysplasia 
 11
0 830/09 70 M 
  
Rectum 
 
Tubular adenoma c low grade 
dysplasia 
 11
1 1010/09 53 M 
  
Anal polyp 
 
Inflammatory polyp 
 11
2 1011/09 47 M 
  
Stomach GC Inflammatory polyp 
 11
3 1140/09 39 M 
  
Duodenum D2 Inflammatory polyp 
 11
4 1211/09 46 M 
  
Colon Transverse Inflammatory polyp 
 11
5 1257/09 51 F 
  
Stomach  Fundus Inflammatory polyp 
 11
6 1268/09 58 M 
  
Stomach Fundus Inflammatory polyp 
 11
7 1386/09 40 M S 
 
Anal canal 
 
Inflammatory polyp 
 11
8 1390/09 30 F 
  
Colon 
 
Adenomatoup polyp with 
malignant transformation 
 11
9 1392/09 80 F P 
 
Stomach  LC Hyperplastic polyp 
 12
0 1425/09 48 F 
  
Stomach Antrum Adenoca mod diff papillary  
 12
1 1450/09 60 F 
  
Stomach  Body Inflammatory polyp 
 12
2 1479/09 38 F 
  
Stomach Body Hyperplastic polyp 
 12
3 1584/09 67 M 
  
Colon 
Asc colon & 
hepatic  flexure Adenoca infiltr mod diff  
 12
4 1656/09 75 M 
  
Caecum 
 
Tubular adenoma 
 12
5 1715/09 53 M 
  
Duodenum 
 
Adenoca well  differentiated 
papillary   
 12
6 1720/09 28 M 
  
Rectum 
 
Inflammatory polyp 
 
12
7 
1828/09 
cr 
599/09 50 M 
  
Stomach Antrum Adenoca 
 12
8 1898/09 19 M 
  
Colon+si 
Ileum.caecum.r
ectum Inflammatory polyps 
 
12
9 1919/09 48 M 
  
Rectum 
A-rectosigmoid 
growth b-rectal 
polyp 
A)mod-poorly diff adenoca 
b)hyperplastic polyp 
 
13
0 2001/09 63 F S 
 
Colon 
 
Adenoca infiltr mucin secreting , 
hyperplastic villi c adenomatous 
changes 
 13
1 2031/09 45 M 
  
Caecum Caecum Inflammatory polyp 
 13
2 2214/09 40 M S 
 
Stomach Antrum Hyperplastic polyp 
 13
3 2227/09 29 M P 
 
Rectum 
 
Hyperplastic polyp 
 
13
4 2229/09 47 M 
  
Colon 
A-growth asc 
colon b-splenic 
flexure polyp A)poorly diff ca b)villous adenoma 
13
5 2280/09 42 M S 
 
Rectum 
 
Hyperplastic polyp 
 13
6 2547/09 71 M S 5 mm Colon Descending Hyperplastic polyp 
 
13
7 2990/09 54 M 
  
A-polypoidal lesion 
d2 b-growth 
esophagus 
 
A)inflammatory polyp b-scc 
 13
8 3010/09 30 F S 
 
Colon 
 
Infiltr  mod-poorly diff adenoca ; 
polyps- villous adenoma, some 
 
with high grade dysplasia 
13
9 3035/09 44 M 
  
Rectum 
 
Hyperplastic polyp 
 
14
0 3075/09 60 M 
  
Colon 
A-colonic 
polyp b-growth 
sigmoid colon 
A)tubulovillous adenoma c low 
grade dysplasia b)infiltr mod diff 
pap adenoca 
 14
1 3110/09 40 F 
  
Anal polyp 
 
Fibroepithelial polyp 
 14
2 3364/09 64 F 
  
A-duodenum b-
antral polyp Antrum 
A)chr non spec duodenitis b-
antral gastritis 
 14
3 3518/09 65 F 
  
Stomach Pylorus Non spec inflammation 
 14
4 3684/09 65 F 
  
Stomach Body Hyperplastic polyp 
 14
5 3711/09 60 M S 
 
Colon Transverse 
Hyperplastic polyp,ulcer- infiltr 
mod diff adenoca Polyp,ulcer 
14
6 3876/09 65 F S 
 
Colon+rectum 
A-desc colon b-
rectum 
A) non spec inflamm b)villous 
adenoma 
 
14
7 4041/09 34 F 
  
Colon 
A-growth 
rectum b-5 
polyps in colon 
Mucinous adenoca,inflammatory 
polyp 
 14
8 4198/09 14 F S 
 
Colon+rectum 
Sigmoid,rectum
,asc colon Inflammatory  polyps 
 
14
9 
4219/10 
cr-
3876/09 65 F 
  
Rectum 
 
Villous adenoma c low grade 
dysplasia c focus showing ca in 
situ 
 15
0 4643/09 42 M 
  
Colon 
 
Tubular adenoma 
Polyposis 
coli  
15
1 4649/09 45 F P 
 
Caecum Caecum TVA 
 
15
2 4741/09 19 M 
S,
p 
1.5*1*1,
0.5*0.5 Colon+rectum 
Asc c, hepatic 
fl,sigm,rectum 
Juvenile polyps c focal 
adenomatous change 
Fap-total 
proctocole
ctomy-
4826/09-
juv poly c 
focal 
adenomato
us change 
15
3 4852/09 42 M 
  
A-D2 polyp b-
stomach body Body A) non spec infl b)hyperplastic p 
 15
4 4858/09 50 M P 
 
Colon 40cm from a.v Tubular adenoma 
 15
5 5149/09 52 M 
 
1*1*0.5 Colon Sigmoid Hyperplastic polyp 
 15
6 5235/09 32 F P 1.5*1*1 Anal polyp 
 
Fibro epithelial polyp 
 15
7 5629/09 65 M 
  
Stomach 
Junction of 
fundus & body Chronic non specific gastritis 
 15
8 5635/09 55 F 
  
Caecum Caecum Non specific colitis 
 
15
9 5642/09 17 M 
  
Duodenum 
 
Hyperplastic polyp 
Acute 
small 
bowel 
obstruction 
16
0 5682/09 47 M 
  
Stomach Body Lymphoma/poorly diff ca 
 16
1 5749/09 60 F 
  
Stomach LC Hyperplastic polyp 
 16
2 5750/09 78 M 
  
Stomach Antrum 
Hyperplastic polyp c mild mod 
dysplasia 
C/o 
dyspepsia 
16
3 5755/09 35 M S 
 
Stomach Distal body Hyperplastic polyp 
 16
4 5952/09 68 M 
  
Colon 
 
Tubular adenoma 
 16
5 6142/09 50 M S 
 
Stomach Antrum Chronic non specific gastritis 
 16
6 6284/09 55 M S 
 
Colon Descending TVA 
 16
7 6413/09 62 F 
  
Rectum 
 
Adenoca infiltrating well diff  
 16
8 6421/09 22 M 
  
Stomach 
Pyloro-
duodenal Tubular adenoma 
 
opening 
16
9 6586/09 32 F 
  
Colon Sigmoid Villous adenoma 
 17
0 6692/09 65 M S 
 
Colon Sigmoid Adenoca mucinous type 
 17
1 6758/09 14 M S 
0.5 to 
0.75 cm  Rectum 
 
Retention polyp  
 17
2 6791/09 28 F S 
 
Esophagus 
 
S/s hyperplastic squamous 
epithelium  with papillomatosis 
 17
3 6802/09 74 M 
  
Colon Sigmoid 
Tubulovillous adenoma + infiltr 
well diff adenoca 
 17
4 6907/09 32 F 
  
Colon Rectosigmoid Adenoca well  differentiated  
 17
5 6936/09 14 F 
  
Rectum 10 cm from av 
Tubular adenoma with high grade 
dysplasia 
 17
6 6987/09 56 M 
  
Colon Desc Tubular adenoma 
 
17
7 7085/09 50 M S 
 
Stomach  Fundus 
Adenoca poorly diff  c 
neuroendocrine 
diff/neuroendocrine ca 
 17
8 7164/09 56 M 
  
Duodenum 
 
Poorly diff adeno ca 
 
17
9 7169/09 75 M 
  
Caecum 
 
Adenoca mucinous  
Multiple 
polyps 
throughout 
colon 
18
0 7202/09 79 M 
  
Colon Sigmoid 
Tubulovillous adenoma c well diff 
adenoca 
 18
1 7376/09 58 F 
  
Rectum 
 
Villous adenoma c low grade 
dysplasia  
 18
2 7547/09 65 M 
  
Esophagus-lower Barrett's esophagitis 
  
18
3 7507/09 55 M 
  
Rectum 
 
Retention polyp 
 18
4 8011/09 60 F 
  
Stomach OGJ,cardia Adenoca well  differentiated  
 18
5 8515/09 74 M 
  
Rectum 
 
Tubular adenoma 
 18
6 8565/09 70 M 
  
Rectum 
 
Non specific colitis 
 18
7 8517/09 30 M S 
5.5*5*3c
m Colon Sigmoid Lipomatous polyp 
 18
8 8766/09 59 M 
  
Stomach Antrum Adenoca infiltrating well diff 
 18
9 8569/09 32 F 
  
Anal polyp 
 
Fibroepithelial polyp 
 
19
0 
8726/09 
cr 
7085/09,
8010/09 50 M S 
Multiple
-largest 
1.7 cm 
smallest 
0.2 cm Stomach Cardia,body Hyperplastic polyps 
 19
1 380/10 47 M 
  
Colon Sigmoid Retention polyp 
 19
2 573/10 35 F 
  
Caecum 
 
Tubular adenoma 
 19
3 1161/10 65 F S 
 
Stomach  LC Hyperplastic polyp 
 19
4 1309/10 75 F 
  
Colon Sigmoid Adenoca well diff  
 19
5 1659/10 75 F 
  
Stomach Antrum Hyperplastic polyp 
 19
6 1663/10 80 M 
  
Colon Sigmoid Tubular adenoma 
 19
7 1792/10  60 F S 
 
Stomach Pylorus 
Adenoca poorly diff  intestinal 
type 
 19
8 2136/10 40 M 
  
Rectum 
 
Villous adenoma 
 19
9 2307/10 40 F 
  
Colon Sigmoid Adenoca infiltr well diff  
 
20
0 2319/10 50 M 
  
Colon 
60 cm from 
anal verge Tubular adenoma 
 
20
1 2370/10 70 M S 
 
Rectum 
A-
ulceronodular 
growth 10-
15cm from anal 
verge b-polyp 
5cm from anal 
verge 
A)infilt mod diff adenoca 
b)tubular adenoma 
 
20
2 2438/10 40 M 
S,
P 
 
Rectum 
Multiple  
polyps 5 cm 
from anal verge Tubulovillous adenoma 
 20
3 2580/10 35 M 
  
Anal polyp 
 
Tubular adenoma 
 20
4 2729/10 60 M 
  
Rectum 
 
Tubular adenoma 
 20
5 3347/10 78 M 
  
Colon Transverse Tubular adenoma 
Abdominal 
pain 
20
6 3523/10 40 M 
  
Stomach Antrum Hyperplastic polyp 
Fundal 
gastritis 
20
7 3554/10 56 M 
  
Duodenum D1,d2 Hyperplastic polyp 
 
20
8 3592/10 15 F 
  
Caecum 
Polypoidal 
mass in 
appendicular 
opening of 
caecum Non spec inflammation 
 20
9 4031/10 68 F 
  
Stomach 
Junction of 
fundus & body Hyperplastic polyp 
 
21
0 4156/10 70 M 
  
Colon 
Rectosigmoid,9 
to 13 cm from 
anal verge Tubular adenomas 
 21
1 4217/10 31 M 
  
Colon Descending Tubular adenoma 
 21
2 4546/10 73 M S 
 
Stomach Distal antrum Hyperplastic polyp 
 21
3 4838/10 51 M 
  
Colon Sigmoid Adenoca well diff pap  
Secondaries 
liver 
21
4 4842/10 70 M S 
 
Rectum+sigmoid 
Sessile at 7-12 
cm from 
AV;pedunculat
ed-18cm from 
AV Hyperplastic polyps 
 21
5 4996/10 28 M 
  
Rectum 
 
Hyperplastic polyp 
 
21
6 5015/10 48 M 
  
Stomach Entire stomach Non spec inflammation 
Hypokalem
ic periodic 
paralysis;re
c vomiting 
21
7 5111/10 22 F 
  
Colon Asc colon Villous adenoma  
 21
8 5121/10 45 M 
  
Duodenum D1,D2 Non spec duodenitis 
 21
9 5248/10 80 M 
  
Duodenum 
 
Chr non spec duodenitis 
 22
0 5294/10 61 M 
  
Rectum 
 
Angiomatous polyp  
 22
1 5420/10 41 M 
  
Duodenum 
 
Brunner gland hyperplasia 
 22
2 5470/10 81 F 
  
Anal 
 
Fibro epthelial polyp 
 22
3 5530/10 40 M 
  
Stomach Antrum Hyperplastic polyp 
 22
4 5554/10 65 M 
  
Anal canal 
 
Adenoca infiltrating well diff  
 
22
5 5969/10 46 M S 
 
Stomach  Entire stomach Non spec inflammation 
Pheochrom
ocytoma,pa
ncreatic 
abscess,mul
tiple polyps 
stomach 
22
6 6263/10 14 M 
  
Anal canal 
 
Hyperplastic polyp 
 
22
7 6382/10 50 M 
  
Rectum 
 
Non spec inflammation 
 22
8 6475/10 45 M 
  
Colon Hepatic flexure 
Adenoca infiltr mod diff with 
extensive ulcer 
 22
9 6477/10 60 M 
  
Stomach OGJ  Adenoca infiltr  poorly diff 
 
23
0 6479/10 65 M 
  
Colon 
Rectosigmoid,3
5 cm from anal 
verge 
Hyperplastic polyp with focal 
adenomatous change 
Ileoileal 
intususcepti
on 
23
1 6560/10 65 M 
  
Ileum 
 
Inflammatory fibroid polyp c torsion 
23
2 6585/10 36 M 
  
Colon Descending Hyperplastic polyp 
 23
3 6656/10 45 M 
  
Caecum Caecum Adenoca infiltr mod  diff  
 23
4 6743/10 37 F 
  
Anal 
 
Fibroepithelial polyp 
 23
5 6745/10 30 F 
  
Duodenum D1.D2 Non spec inflammation 
 23
6 6849/10 61 M 
  
Anal canal 
 
Hyperplastic polyp 
Post renal 
transplant 
23
7 6877/10 39 M 
 
3x4 mm Esophagus Just above OGJ Non spec inflammation 
 23
8 6936/10 30 F 
  
Anal polyp 
 
Fibrepithelial polyp 
 
23
9 6962/10 46 M 
  
Stomach 
Pyloro 
duodenal 
junction Non spec inflammation 
 24
0 7148/10 62 M 
  
Stomach Fundus Non specific gastritis 
 
24
1 7193/10 65 M 
  
Rectum 
A-rectal polyp 
5cm from anal 
verge b-
multiple friable 
sessile 
polypoidal 
lesions in distal 
desc colon 
A)tubular adenoma B)well diff 
infiltr adeno ca 
 
24
2 7194/10 74 M S 
 
Anal 
 
Chronic non-spec inflammation 
Ca trans 
colon;post 
hemi 
colectomy 
24
3 7259/10 55 M S 
 
Rectum 
 
Inflammatory polyp 
 24
4 7313/10 59 M 
  
Caecum Caecum Flat adenoma 
 24
5 7336/10 41 M 
  
Caecum Caecum Non spec inflammation 
 24
6 7411/10 22 M P  
 
Anal 
 
Fibroepithelial polyp 
Post GJ 
status 
24
7 7790/10 41 M 
  
Caecum Caecum Hyperplastic polyp 
 24
8 7797/10 26 M 
  
Anal 
 
Fibroepithelial polyp 
 24
9 7846/10 61 M 
  
Anal canal 
 
Hyperplastic polyp c focal 
adenomatous changes 
 25
0 7854/10 54 M S 
 
Caecum Caecum Crohn's disease 
 25
1 7855/10 44 M P 
 
Colon Descending Tubular adenoma 
 25
2 7862/10 23 F 
  
Anal polyp 
 
Fibroepithelial polyp 
 25
3 8293/10 32 M S 
 
Ileum 
 
Non specific inflammation  
 25
4 8328/10 52 F 
  
Anal 
 
Fibroepithelial polyp 
 25
5 8426/10 53 M S 
 
Caecum Caecum Hyperplastic polyp 
 
25
6 8720/10 42 M S 
 
Colon 
A-rectal growth 
b-multiple 
polyps colon 
B-tubulovillous adenoma c high 
gr dysplasia b-mucin secreting 
infiltr adenoca (mod diff stage b2) 
 25
7 8628/10 40 F S 
 
Stomach Body Chronic non specific gastritis 
 
25
8 8844/10 24 M 
 
1.5cm Colon Rectosigmoid Tubulovillous adenoma 
 
25
9 8920/10 65 M 
  
Colon Rectosigmoid 
Tubulovillous adenoma c low gr 
dysplasia & focal areas showing 
high grade dysplasia 
Dyspepsia/
GERD 
26
0 8962/10 70 M S 
 
Duodenum 
 
Hyperplastic polyp 
 26
1 8972/10 39 F 
  
Anal polyp 
 
Fibroepithelial polyp 
 26
2 9026/10 36 F S 
 
Caecum Caecum 
Non specific inflammatory 
pathology 
 26
3 9027/10 63 F P 
 
Colon Descending TVA 
 26
4  9159/10 65 M S 
 
Duodenum D1 Carcinoid 
 26
5 9188/10 61 M 
  
Stomach Antrum Hyperplastic polyp 
 26
6 9230/10 45 F 
  
Colon Asc Adenoca infiltr well diff  
 26
7 9500/10 40 F S 
 
Stomach 
Junction of 
body & antrum Tubulovillous adenoma 
 
26
8 47/11 55 F P 0.5 cm Colon Sigmoid Tubular adenoma 
Markedly 
inflamed 
colonic 
mucosa 
26
9 151/11 25 F 
  
Colon 
 
Pseudopolyp-ulcerative colitis 
 
27
0 155/11 70 M 
  
A-ulcer lc stomach 
b-duodenal bulbar 
polyp 
 
A)infiltr adenoca mod diff (b) 
ulcerated hyperplastic polyp 
 
27
1 393/11 70 M 
 
2x1x1c
m Rectum 
 
TVA with malignant 
transformation into well diff 
adenoca 
 27
2 562/11 48 M S 
 
Colon Asc Tubular adenoma Cirrhosis, 
27
3 609/11 70 F 
  
Stomach 
Mutiple-
antrum,fundus 
Hyperplastic polyp c mild 
inflammation 
 27
4 618/11 58 M S 
 
Colon 
 
Tubular adenoma 
 27
5 619/11 50 M S 
 
Colon 
A-anal ulcer b-
caecal polyp 
A-infiltr SCC well diff b-
hyperplastic polyp 
 
27
6 647/11 30 F P 
 
Stomach LC Chronic lymphocytic gastritis 
Growth 
rectum-post 
APR 
27
7 659/11 70 M S 
 
Colon Sigmoid Hyperplastic polyp 
Intussuscep
tion 
27
8 726/11 30 F P 
3x2x2c
m Ileum 
 
Peutz jeghers polyp 
 27
9 790/11 54 F 
  
Colon Descending Lipomatous polyp 
 28
0 800/11 62 M S 
 
Colon Ascending Hyperplastic polyp 
 28
1 1184/11 56 F 
  
Colon Descending Pseudopolyp inflammatory 
 28
2 1231/11 30 F 
  
Colon Rectosigmoid Villous adenoma 
 28
3 1248/11 63 M 
 
0.5x0.5c
m Esophagus At 27cm 
Hyperplastic squamous 
epithelium 
 28
4 1343/11 61 M 
  
Colon Splenic flexure Hyperplastic polyp 
 28
5 1387/11 56 M S 
 
Colon 
 
Non specific inflammation 
 28
6 1513/11 68 M 
  
Stomach OGJ Hyperplastic polyp 
 28
7 1571/11 70 M 
  
Stomach Body Lymphocytic gastritis 
 28
8 1606/11 62 M S 
 
Colon Asc Hyperplastic polyp 
 28
9 1623/11 21 F 
  
Stomach Pre pyloric Chronic lymphocytic gastritis 
 
29
0 1644/11 28 F 
  
Anal   
 
Fibroepithelial polyp 
Tubo-
ovarian 
mass-
paraovarian 
simple 
serous cyst 
29
1 
1662/11 
cr-
1231/11 30 F 
  
Colon Sigmoid Tubulo villous adenoma 
 
29
2 1963/11 65 M 
  
Colon Rectosigmoid Tubular adenoma 
Multiple 
poyps 
throughout 
colon,lips 
pigmentatio
n+?PJ 
syndrome 
29
3 2028/11 20 M 
  
Duodenum D2 Hyperplastic polyps 
 29
4 2037/11 55 F 
  
Stomach Antrum Hyperplastic polyp 
 
29
5 2190/11 44 F 
  
Stomach 
A-
ulceroproliferati
ve  growth 
distal 
body,antrum b-
pyloric polyp 
A)infiltr adeno ca signet ring cell 
type b-)chronic lymphocytic  
gastritis dysphagia 
29
6 2378/11 45 F 
  
Stomach Pylorus Inflammatory polyp 
 29
7 2380/11 66 M 
  
Colon Ascending Adeno ca well diff papillary type 
 29
8 2381/11 54 M P 
 
Colon 
Sigmoid,30cm 
from AV Tubulovillous adenoma 
 29
9 2424/11 50 M P 
 
Esophagus At 35cm 
Hyperplasia of squamous 
epithelium & papillomatosis 
 
30
0 2515/11 66 M 
S,
P 
 
Rectum 
 
Tubular adenoma & hyperplastic 
polyp with focal adenomatous 
change 
 30
1 1972/11 23 F 
  
Anal 
 
Fibroepithelial polyp 
 
30
2 
3355/11 
cr-
2960/11 23 M 
S,
P 
 
Colon 
 
Tubulovillous adenoma 
 30
3 3776/11 53 M 
  
Anal 
 
Retention polyp 
 30
4 4708/11 35 F 
  
Colon Transverse Adenoca well diff  
 30
5 5063/11 60 F S 
 
Stomach Body 
Hyperplastic polyp with severe 
inflammation 
 30
6 6109/11 40 F 
  
Anal 
 
Fibroepithelial polyp 
bleeding 
PR 
30
7 7630/11 55 F 
  
Colon 
Sigmoid & 
rectum Pseudopolyp 
 30
8 7912/11 49 M 
  
Colon Hepatic flexure Retention polyp 
 30
9 8197/11 54 F 
  
Stomach Antrum Adenoca mod diff  
 31
0 8496/11 56 M S 
 
Rectum 
 
Inflammatory polyp 
 31
1 8839/11 21 M 
  
Duodenum D1 Hyperplastic polyp 
 31
2 2595/11 50 F 
  
Rectum 
 
Hyperplastic polyp 
 31
3 2709/11 35 M 
  
Jejunum 
 
Peutz jeghers polyp 
 31
4 2960/11 30 M 
  
Colon 
 
Tubulovillous adenoma 
 31
5 2963/11 40 M S 3 mm Esophagus 
 
Fibroepithelial polyp 
 
31
6 
3041/11 
cr-
2028/11 20 M 
  
Colon Rectosigmoid Tubular adenoma 
 31
7 3156/11 23 M P 2x2cm Rectum 
 
Tubulovillous adenoma with focal 
moderate  dysplastic changes  
 31
8 3252/11 65 M P 
 
Duodenum D1,d2 Brunner gland hyperplasia 
 31
9 3395/11 35 F 
  
Rectum 
 
Adenoca infiltrating , TVA 
 
32
0 3622/11 31 M 
  
Stomach Antrum Hamartomatous polyp 
 
32
1 3849/11 32 M 
  
A-stomach b-
multiple polyps 
d1,d2 
 
A-mod diff adenoca b-non spec 
infl 
 32
2 3904/11 45 M S 0.5cm Stomach Fundus Nonspec inflammation 
 32
3 3907/11 32 M 
S,
P 
 
Colon 
 
Tubular adenoma  
 
32
4 
3924/11 
cr-
3077/11 66 M 
  
Colon Ascending Villous adenoma 
 32
5 3972/11 28 F S 
 
Stomach Antrum Non spec inflammation 
 32
6 3975/11 58 M S 
 
Colon Transverse Nonspec inflammation 
 32
7 4102/11 45 M 
  
Rectum 
 
Adenoca papillary  with areas of 
extracellular mucin 
 
32
8 4203/11 30 M 
  
Colon 
Descanding 
,splenic 
flexure,distal 
colon Flat adenoma 
 32
9 4357/11 49 M 
  
Colon 
 
Nonspec inflammation 
 
33
0 4427/11 61 M P 
 
A-duodenum b-
stomach 
A-D2 b-
prominent 
ampulla c-
ulceroproliferati
ve  lesion cardia 
& fundus 
A-adenomatous polyp b-ulcer c-
adenoca well diff 
 33
1 4821/11 41 M 
  
Stomach Body LC  Adenoca poorly diff 
 
33
2 4938/11 23 M S 
 
Stomach OGJ Inflammatory polyp 
Ct 
abdomen-
?Leiomyom
a 
33
3 4974/11 45 M 
  
Stomach Fundus Inflammatory fibroid polyp 
 
33
4 
5213/11 
cr-
3881/11 22 M 
  
Colon Rectosigmoid 
Infiltr well diff adenoca+tva with 
high grade dysplasia 
 
33
5 5219/11 36 F 
  
Stomach Antrum Chronic non-spec gastritis 
Gastric 
outlet 
obstruction 
33
6 5230/11 70 F 
  
Stomach Antrum Chronic non-spec gastritis 
Polypoidal 
growth in 
fundus with 
ulcer with 
bleed; 
HIV+; 
previous 
biopsy - 
adenomato
us polyp 
33
7 5438/11 59 M 
  
Stomach Fundus GIST 
 33
8 5476/11 27 M P 
 
Caecum Caecum Tubular adenoma 
 
33
9 5487/11 61 M S 0.5cm Colon 
A-growth 
descending  
colon b-polyps 
colon Adenoca infiltr well diff  
Post GJ 
status 
34
0 5555/11 61 M 
  
Jejunum Peristomal Ulcer 
 
34
1 5601/11 39 F 
  
Duodenum 
 
Chronic non-spec duodenitis 
Rectal 
mucosa 
inflammed; 
multiple 
polypoidal 
lesions 
from 
sigmoid c 
upto 
caecum 
34
2 5630/11 29 F 
  
Colon+rectum 
A-right colon b-
transverse 
colon; c-left 
colon; d-rectum Nhl diffuse type 
 
34
3 
5749/11 
cr-
5487/11,
4427/11 61 M 
  
Stomach,colon 
A-
gastrectomy;b-
right 
hemicolectomy 
Stomach-GIST ; colon-infiltr 
adenoca  
Anemia,dys
pepsia 
34
4 5753/11 53 M 
  
Stomach Antrum Adenoca infiltr well diff  
polypoid 
lesion 5cm 
above anal 
verge 
34
5 5755/11 30 F 
  
Rectum 
A-multiple bx 
rectum b-polyp 
rectum A,b-ulcerative colitis active phase 
 
34
6 5824/11 50 M 
  
Caecum Caecum Chronic non-spec colitis 
Multiple 
polyps 
throughout 
colon 
34
7 5838/11 24 M 
  
Colon 
20 cm from 
anal verge Peutz jeghers polyp 
Chronic 
kidney 
disease 
34
8 5840/11 37 M 
  
Duodenum Bulb Hyperplastic polyp 
Peptic ulcer 
disease/gast
ric outet 
obstruction 
34
9 5925/11 70 M 
  
Stomach Pylorus Hyperplastic polyp with ulcer 
Bleeding 
per-rectum 
35
0 6032/11 36 F 
  
Rectum 
 
Juvenile polyp 
 
35
1 6711/11 70 M 
S,
P 
A-
0.75cc;b
-1cc Colon+rectum 
Descending  
colon, rectum 
Tubular adenomas with mild 
atypia 
 
35
2 6712/11 45 M 
  
Colon+rectum 
A-desc c;b-
rectum(15 cm 
from anal 
verge) 
A-tva mild dysplasia;b-tva severe 
dysplasia 
Ca rectum 
with liver 
sec;post 
ct/rt;ulcero
prolif 
lesion from 
3cm to 7cm 
of anal 
verge 
35
3 6878/11 54 F 
  
Colon Rectum 
Adenoca poorly diff signet ring 
cell with adenomatous polyp 
 35
4 6879/11 32 M 
 
2-3mm Rectum 
 
Tubular adenoma 
 
35
5 7144/11 54 M S 
 
Colon Caecum Non-spec inflammation 
Ibs;old 
hyperplasti
c polyp 
35
6 7145/11 69 M S 
 
Colon 
A-descending 
colon; b-polyp 
sigmoid 25cm 
from AV Non spec inflammation 
 35
7 7146/11 51 M 
  
Stomach Antrum Hyperplastic polyp with ulcer 
 35
8 7568/11 49 F 
  
Stomach Antrum Hyperplastic polyp 
 
35
9 7615/11 28 M 
  
Colon+stomach 
A-gastric 
mucosa; b-
colonic polyps A-hyperplastic polyp ; b-TVA 
 36
0 8003/11 75 F P 
 
Stomach 
Lesser 
curvature Tubulovillous adenoma 
 36
1 8006/11 56 F 
  
Stomach Antrum Hyperplastic polyp 
 36
2 8076/11 85 M S 
 
Colon Splenic flexure Non-spec inflammation 
 
36
3 
8118/11 
cr-
7048/11 53 M 
  
Colon Ascending Adenoca infiltr mod diff  
 
36
4 8239/11 48 F 
  
Esophagus Just above OGJ Barrett's esophagitis 
 36
5 8561/11 37 F 
  
Rectum 
 
Non-spec inflammation 
 36
6 8610/11 50 M S 
 
Duodenum D1 Non-spec duodenitis 
 36
7 8766/11 55 F P 
 
Colon Descending Tubular adenoma 
 36
8 8809/11 40 M 
  
Colon Ascending Tubular adenoma 
 36
9 8881/11 55 M S 
 
Colon Ascending Adenoca infiltr well diff  
 37
0 8882/11 57 M S 
 
Colon Descending TVA 
Ca rectum ; 
APR done 
37
1 8932/11 75 M S 
 
Caecum 
On ileocaecal 
valve Adenoca well diff  
 
37
2 8954/11 25 F 
  
Rectum+caecum 
A-polypoidal 
lesion 
rectosigmoid; 
b- biopsy from 
ileocaecal valve 
A- Tubular adenoma 
B- tuberculosis 
 37
3 8958/11 59 M 
  
Duodenum D2,D3 TVA 
 37
4 8995/11 42 M 
  
Colon Descending Tubular adenoma 
 37
5 9157/11 41 M 
  
Colon Caecum Tubular adenoma 
 37
6 9350/11 67 F 
  
Stomach Pylorus Hyperplastic polyp 
 37
7 9389/11 39 M 
  
Duodenum D2 Non-spec duodenitis 
 
37
8 9461/11 26 M P 1.5x1cm Rectum 
A-rectosigmoid 
b-rectal p 5cm 
from anal verge A-ulcerative colitis b- TVA 
SOL liver, 
grade 1 
esophageal 
varices 
37
9 9589/11 75 M S 
 
Duodenum 
 
Non-spec duodenitis 
 38
0 9770/11 60 M 
  
Rectum 
 
TVA 
 
38
1 9789/11 48 M 
  
Colon 
A-descending ; 
b-transverse 
colon Crohn's disease 
 
38
2 
10000/1
1 60 M 
  
Anal polyp;rectal 
growth 
A-polyp 
1.5x2cm;b-
noduloprolif 
growth from 4 
to 10 cm of av 
A-TVA; B- infiltr well diff 
adenoca 
 38
3 
10003/1
1 18 M 
  
Jejunum 
 
Tubular adenoma 
 
38
4 
10008/1
1 60 M P 
 
Colon Sigmoid TVA 
Nodular 
lesion distal 
ileum, 
chronic 
diarrhoea 
38
5 
10103/1
1 14 M 
  
Ileum 
 
Non spec  inflammation 
 38
6 
10240/1
1 26 M 
  
Rectum 
 
Retention polyp 
 38
7 
10297/1
1 50 F 
  
Colon 40cm from AV 
Tubular adenomatous polyp with 
no dysplasia 
 38
8 
10303/1
1 65 F 
  
Stomach Fundus Hyperplastic polyp 
 38
9 
10312/1
1 55 F 
  
Stomach Antrum Hyperplastic polyp 
 39
0 
10339/1
1 38 M 
  
Colon+rectum 
A-colon;b- 
rectal Tubular adenomas 
Antral 
gastritis 
39
1 
10344/1
1 66 F 
  
Stomach Fundus Hyperplastic polyp 
 39
2 
10352/1
1 61 M 
  
Stomach Body lc Adenoca infiltr mucinous type 
 
39
3 201/12 55 M 
  
Colon 
A-polypoidal 
lesion asc 
colon;b-
A-infiltr mod diff adenoca; b-
TVA 
 
multiple 
colonic polyps 
39
4 245/12 34 M 
  
Colon 
A-growth asc 
colon;b-
diminutive 
polyp Inflammatory polyps 
 39
5 255/12 57 M 
  
Colon Hemicolectomy TVA;infiltr well diff adenoca 
 39
6 400/12 50 M 
  
Stomach Pylorus 
Adenoca infiltr mod diff papillary 
intestinal type 
 
39
7 425/12 30 M S 
 
Colon 
A-mid asc 
colon polypoid 
growth b-
descending 
colon polyp 
A-infiltr mod diff adenoca; b-
tubular adenoma 
 39
8 493/12 40 F S 
 
Stomach Body Hyperplastic polyp 
 39
9 502/12 55 M S 
 
Colon Transverse Tubulovillous adenoma 
 
40
0 589/12 50 M 
  
Colon 
A-multiple 
polyps b-
polypoid 
growth in 
descending 
colon 
A-nonspecific ulcer b-tubular 
adenoma 
 40
1 592/12 40 F 
  
Anal 
 
Inflammatory pseudopolyp 
 
40
2 651/12 66 M 
  
Rectum 
A-small polyp 
at 17cm from 
AV(rectum) b-
growth 
anorectum 
(from above 
anal verge to 
upto 8cm) 
A-hyperplastic polyp; B-
adenocarcinoma papillary type 
 
40
3 656/12 29 F 
  
Stomach 
Polypoidal 
lesion at OGJ & 
cardia Chronic lymphocytic gastritis 
 
40
4 
761/12 
cr-
9788/11 30 F 
  
Jejunum 
 
Tubular adenoma 
 40
5 785/12 66 M 
 
<0.5cm Rectum 
 
Inflammatory pseudopolyp 
 
40
6 975/12 70 M 
  
Colon  
A-polypoidal 
lesion 
ileocaecal 
region b-
<0.5cm polyp 
in desc colon 
A-nonspec inflammation  b-
tubular adenoma 
 40
7 1060/12 57 M 
 
<0.5 cm Rectum 
 
Tubular adenoma with superficial 
ulceration 
 40
8 1298/12 60 F 
  
Rectum 
 
Hyperplastic polyp 
 40
9 1407/12 51 M 
  
Colon Rectosigmoid Tubular adenoma 
 
41
0 1442/12 42 F 
 
0.5x0.5c
m Colon 
A-hyperemic 
area in caecum 
b-pedunculated 
polyp sigmoid 
colon 
A-chronic non-specific colitis b-
hyperplastic polyp 
 41
1 1510/12 50 F S 
 
Colon Descending Hyperplastic polyp 
 41
2 1511/12 65 M 
  
Colon 
Ascending & 
transverse Tubular adenoma 
 41
3 1542/12 36 M 
  
Duodenum 
 
Hyperplastic polyp 
 41
4 1941/12 65 M 
  
Colon Descending Hyperplastic polyp 
 41
5 1958/12 70 F 
  
Rectum 
 
Tubular adenoma 
 41
6 2032/12 37 M P 
 
Anal 
 
Malignant melanoma 
 
41
7 2070/12 57 F 
  
Colon r+l 
A-polypoidal 
lesion above 
ileocaecal valve 
b-polypoidal 
lesion in 
descending 
colon 
A-inflammatory polyp b-tubular 
adenoma 
 41
8 2071/12 58 M P 
 
Stomach Antrum Hyperplastic  polyp 
 41
9 2190/12 60 M 
  
Anal 
 
Hyperplastic polyp 
 42
0 2270/12 65 F S 
 
Duodenum D1 
Inflammatory pseudopolyp -? 
H.pylori duodenitis 
 
42
1 2312/12 65 M 
  
Colon 
 
Tubular adenoma 
C/o 
constipatio
n 
42
2 2325/12 76 M 
  
Colon Descending Tubular adenoma 
 42
3 2350/12 38 M 
  
Colon Descending 
Tubular adenoma with mild 
dysplasia 
 42
4 2521/12 21 F S 
 
Caecum Caecum Hyperplastic polyp 
 42
5 2528/12 55 M S 
 
Colon Hepatic  flexure TVA 
 42
6 2538/12 53 M S 
 
Colon Transverse 
Well diff adenoca, tubular 
adenomas 
 
42
7 2598/12 45 M 
  
Rectum 10 cm from AV Tubular adenoma 
?Inflammat
ory Bowel 
Disease 
42
8 2804/12 40 F S 
 
Colon Sigmoid Non-specific inflammation 
 42
9 2994/12 55 F S 
 
Stomach Fundus Tubular adenoma 
 43
0 2997/12 50 M 
  
Stomach Fundus Hyperplastic polyp 
 43
1 3003/12 45 F S 
 
Stomach Prepyloric Hyperplastic polyp 
 43
2 3386/12 45 F 
  
Rectum 
 
TVA 
 43
3 3444/12 50 F 
  
Stomach Pylorus Hyperplastic polyps 
 43
4 3800/12 20 F P 
 
Colon Descending TVA 
 43
5 4110/12 78 F P 
3cmx2c
m Colon Sigmoid 
Villous adenoma with mod to 
severe dysplastic changes 
 
43
6 
4233/12 
cr-
4110/12 78 F P 
2cmx1c
m Colon 
Sigmoid & 
ascending 
Villous adenoma with severe 
dysplasia with e/o intramucosal 
carcinoma 
 43
7 4313/12 33 M S 
 
Colon Sigmoid Hyperplastic polyp 
 
43
8 4466/12 68 M S 
 
Colon+small 
intestine 
A-d3 b-mid 
transverse 
colon 
A-chronic lymphocytic duodenitis 
b-hyperplastic polyp 
 43
9 4468/12 39 M 
  
Stomach 
Lesser 
curvature 
Hyperplastic polyp/non spec 
inflammation 
 44
0 4668/12 39 F 
  
Stomach Body Hyperplastic polyp 
 44
1 4675/12 49 M P 
 
Colon Sigmoid Inflammatory pseudopolyp 
Bleeding 
PR 
44
2 4744/12 56 M 
 
Diminuti
ve Rectum 
 
Hyperplastic polyp 
 44
3 4746/12 70 F 
  
Stomach Beyond OGJ Non spec inflammation 
Ulcerative 
colitis 
44
4 4960/12 52 M 
  
Caecum Caecum Inflammatory pseudopolyp 
Bleeding 
PR; mass 
descending 
PR 
44
5 4993/12 56 F S 
4cmx3c
mx1cm Rectum 
 
TVA with malignant 
transformation 
 44
6 5001/12 60 M 
  
Rectum 6 cm from AV Well diff adenoca 
 44
7 5051/12 45 F 
  
Stomach Proximal  body Non specific  erosive gastritis 
 
44
8 5052/12 60 F 
  
Stomach Antrum Hyperplastic polyp Two polyps 
44
9 5107/12 20 F P 
2cmx2c
mx1cm Colon Sigmoid Peutz jeghers polyp(a&b) 
 45
0 5395/12 34 F 
  
Colon Transverse Tubular adenoma 
 
45
1 5477/12 64 M S 
 
Colon 
 
Hyperplastic polyp 
Multiple 
polyps 
throughout 
colon 
45
2 5520/12 39 M 
  
Colon 
Descending, 
transverse Tubular adenoma 
 IMMUNOHISTOCHEMISTRY : 
SL
.N
O BX.NO 
A
G
E 
SE
X CARCINOMA 
p5
3 
bc
l2 
POLY
P 
p5
3 
b
cl
2 
COM
PARA
TIVE 
POLY
P BX.NO 
AGE/S
EX 
p5
3 
bc
l2 
1 425/12 30 M 
MOD DIFF INFILTR 
ADENOCA P P TA P P TA 3907/11 32/M N P 
2 5213/11 22 M WELL DIFF ADENOCA N N TA N P TA 1444/08 22/M P N 
3 2370/10 70 M MOD DIFF ADENOCA P N TA P P TA 2729/10 60/M N P 
4 149/09 44 F 
MOD DIFF INFILTR 
ADENOCA P N TA N P TA 1616/08 51/F N N 
5 7193/10 65 M WELL DIFF ADENOCA P N TA N P TA 6711/11 70/M P P 
9 3541/08 55 M 
WELL DIFF PAPILLARY  
ADENOCA N N TVA P P TVA 2528/12 55/M N P 
7 201/12 55 M 
MOD DIFF INFILTR 
ADENOCA P P TVA P P TVA 10008/11 60/M P P 
8 
10000/1
1 60 M 
WELL DIFF INFILTR 
ADENOCA P N TVA N P TVA 8882/11 57/M P P 
6 3395/11 35 F 
MOD DIFF INFILTR 
ADENOCA N N TVA P P TVA 1662/11 30/F P P 
10 8720/10 42 M 
MOD DIFF MUCIN 
SECRETING 
INFILTRATING 
ADENOCA  P P TVA P P TVA 6712/11B 45/M P P 
11 3075/09 60 M 
MOD DIFF INFILTR 
PAP CA P P TVA N P TVA 502/12 55/M N P 
12 952/08 53 M 
POORLY DIFF 
MUCINOUS ADENOCA N N TVA N P TVA 8548/08 55/M N N 
13 255/12 57 M 
WELL DIFF INFILTR 
ADENOCA P N TVA P P TVA 8920/10 65/M N N 
14 3010/09 30 F 
MOD DIFF INFILTR 
ADENOCA P P VA P P VA 6586/09 32/F N N 
15 2229/09 47 M 
POORLY DIFF 
ADENOCA P P VA P N VA 662/09 55/M N N 
16 6907/09 32 F WELL DIFF ADENOCA N N VA N N VA 1231/11 30/F P P 
 
 
SL.NO BX.NO AGE/SEX CARCINOMA p53 bcl2 POLYP p53 bcl2 
17 6878/11 54/F 
POORLY DIFF SIGNET RING 
CELL CARCINOMA P P TA N P 
18 7202/09 79/M WELL DIFF ADENOCA P N TVA P N 
19 393/11 70/M WELL DIFF ADENOCA P N TVA P N 
20 4993/12 56/F MOD DIFF ADENOCA P N TVA P N 
21 4233/12 78/F WELL DIFF ADENOCA P N VA P N 
 
KEY TO MASTERCHART: 
TA – tubular adenoma     TVA – tubulovillous adenoma 
  
VA – villous adenoma MOD DIFF – moderately 
differentiated 
ADENOCA or AC – adenocarcinoma   INFILTR – Infiltrating 
P – positive      N – negative    
M-male       F-female 
AV-anal verge NON-SPEC INFLAM – non-specific 
inflammation 
S/P – solitary/pedunculated    LC-lesser curvature of stomach              
GC- greater curvature of stomach   Asc colon – ascending colon 
SCC – Squamous Cell Carcinoma 
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